Healthcare Services (HCSG) 10-K 17 Feb 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Feb. 15, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	0-12015
Entity Registrant Name	HEALTHCARE SERVICES GROUP, INC.
Entity Incorporation, State Code	PA
I.R.S. Employer Identification No.	23-2018365
Entity Address, Address Line One	3220 Tillman Drive
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Bensalem
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19020
City Area Code	215
Local Phone Number	639-4274
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	HCSG
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 1,060
Entity Common Stock, Shares Outstanding		74,390,448
Documents Incorporated by Reference	Portions of the definitive Proxy Statement for the Registrant’s Annual Meeting of Shareholders to be held on May 30, 2023 have been incorporated by reference into Parts II and III of this Annual Report on Form 10-K.
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Central Index Key	0000731012

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Auditor Information [Abstract]
Auditor Name	GRANT THORNTON LLP
Auditor Location	New York, New York
Auditor Firm ID	248

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)		Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 26,279,000	$ 70,794,000
Marketable securities, at fair value		95,200,000	114,396,000
Accounts and notes receivable, less allowance for doubtful accounts of $70,192 and $59,271 as of December 31, 2022 and 2021, respectively		336,777,000	293,388,000
Inventories and supplies		21,164,000	26,015,000
Taxes receivable		6,629,000	8,813,000
Prepaid expenses and other assets		22,583,000	32,976,000
Total current assets		508,632,000	546,382,000
Property and equipment, net		22,975,000	28,102,000
Goodwill		75,529,000	74,755,000
Other intangible assets, less accumulated amortization of $32,738 and $27,879 as of December 31, 2022 and 2021, respectively		15,946,000	20,805,000
Notes receivable — long–term portion, less allowance for doubtful accounts of $3,273 and $6,312 as of December 31, 2022 and 2021, respectively		32,609,000	29,259,000
Deferred compensation funding, at fair value		33,493,000	46,691,000
Deferred tax asset		28,338,000	31,535,000
Other long-term assets		812,000	0
Total assets		718,334,000	777,529,000
Current liabilities:
Accounts payable		68,296,000	64,419,000
Accrued payroll and related taxes		42,704,000	68,664,000
Other accrued expenses		17,835,000	26,741,000
Borrowings under line of credit		25,000,000	0
Deferred compensation liability — short-term		1,618,000	6,991,000
Accrued insurance claims		23,166,000	24,310,000
Total current liabilities		178,619,000	191,125,000
Accrued insurance claims — long-term		65,541,000	65,084,000
Deferred compensation liability — long-term		33,764,000	46,888,000
Lease liability — long-term		8,097,000	11,299,000
Other long-term liabilities		6,141,000	10,456,000
Commitments and contingencies (Note 16)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 100,000 shares authorized; 76,161 and 76,009 shares issued, and 74,088 and 73,769 shares outstanding as of December 31, 2022 and 2021, respectively		762,000	760,000
Additional paid-in capital		302,304,000	294,124,000
Retained earnings		154,495,000	183,957,000
Accumulated other comprehensive (loss) income, net of taxes		(3,477,000)	4,000,000
Common stock in treasury, at cost, 2,073 and 2,240 shares as of December 31, 2022 and 2021, respectively		(27,912,000)	(30,164,000)
Total stockholders’ equity	[1]	426,172,000	452,677,000
Total liabilities and stockholders’ equity		$ 718,334,000	$ 777,529,000
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts, current	$ 70,192	$ 59,271
Accumulated amortization of other intangible assets	32,738	27,879
Allowance for doubtful accounts, noncurrent	$ 3,273	$ 6,312
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	100,000,000	100,000,000
Common stock issued (in shares)	76,161,000	76,009,000
Common stock outstanding (in shares)	74,088,000	73,769,000
Common stock in treasury (in shares)	2,073,000	2,240,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues		$ 1,690,176	$ 1,641,959	$ 1,760,303
Operating costs and expenses:
Costs of services provided		1,496,336	1,415,082	1,492,317
Selling, general and administrative expense		140,344	173,108	150,778
Other (expense) income:
Investment and other (expense) income, net		(5,427)	9,439	13,352
Interest expense		(2,987)	(1,385)	(1,374)
Income before income taxes		45,082	61,823	129,186
Income tax provision		10,452	15,960	30,504
Net income	[1]	$ 34,630	$ 45,863	$ 98,682
Per share data:
Basic earnings per common share (in dollars per share)		$ 0.47	$ 0.61	$ 1.32
Diluted earnings per common share (in dollars per share)		$ 0.47	$ 0.61	$ 1.32
Weighted average number of common shares outstanding:
Basic (in shares)		74,336	74,816	74,696
Diluted (in shares)		74,351	74,962	74,785
Comprehensive income:
Net income	[1]	$ 34,630	$ 45,863	$ 98,682
Other comprehensive income:
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes		(7,477)	(1,563)	2,644
Total comprehensive income	[1]	$ 27,153	$ 44,300	$ 101,326
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	[1]	$ 34,630	$ 45,863	$ 98,682
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization		15,316	14,667	14,268
Bad debt provision		31,969	10,483	9,636
Deferred income tax expense (benefit)		5,049	3,074	(5,893)
Share-based compensation expense		9,214	8,827	7,872
Amortization of premium on marketable securities		2,219	2,275	1,822
Unrealized loss (gain) on deferred compensation fund investments		9,422	(6,397)	(9,390)
Changes in fair value of other long-term liabilities		(2,353)	0	0
Loss on sale of assets		1,138	1,469	1,335
Changes in operating assets and liabilities:
Accounts and notes receivable		(78,707)	(37,185)	46,158
Inventories and supplies		4,851	5,599	4,931
Prepaid expenses and other assets		9,935	(12,250)	(756)
Deferred compensation funding		3,913	6,661	(52)
Accounts payable and other accrued expenses		(13,748)	10,244	(7,250)
Accrued payroll, accrued and withheld payroll taxes		(24,388)	(22,189)	59,527
Income taxes receivable / payable		2,184	(8,420)	(8,075)
Accrued insurance claims		(687)	6,966	(5,194)
Deferred compensation liability		(18,124)	7,421	9,592
Net cash (used in) provided by operating activities		(8,167)	37,108	217,213
Cash flows from investing activities:
Disposals of fixed assets		393	211	274
Additions to property and equipment		(5,210)	(5,687)	(4,341)
Purchases of marketable securities		(2,875)	(20,335)	(39,047)
Sales of marketable securities		10,386	26,697	6,269
Cash paid for acquisitions		(114)	(23,876)	0
Net cash provided by (used in) investing activities		2,580	(22,990)	(36,845)
Cash flows from financing activities:
Dividends paid		(63,373)	(62,226)	(60,705)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan		106	92	93
Proceeds from the exercise of stock options		410	2,425	2,920
Purchases of treasury stock		0	(21,535)	0
Short-term borrowings, net of repayments		25,000	0	(10,000)
Payments of statutory withholding on net issuance of restricted stock units		(1,071)	(1,410)	(675)
Net cash used in financing activities		(38,928)	(82,654)	(68,367)
Net change in cash and cash equivalents		(44,515)	(68,536)	112,001
Cash and cash equivalents at beginning of the period		70,794	139,330	27,329
Cash and cash equivalents at end of the period		26,279	70,794	139,330
Supplementary cash flow information:
Cash paid for interest		2,822	1,385	1,374
Cash paid for income taxes		3,309	21,233	44,865
Accrued variable consideration for acquisition of businesses		$ 0	$ 10,456	$ 0
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands		Total		Adjustment to adopt credit-loss guidance, net of tax	[1]	Adoption, adjusted balance	[1]	Common Stock	Common Stock Adoption, adjusted balance	Additional Paid-in Capital	Additional Paid-in Capital Adoption, adjusted balance	Accumulated Other Comprehensive Income (Loss), net of Taxes	Accumulated Other Comprehensive Income (Loss), net of Taxes Adoption, adjusted balance	Retained Earnings	Retained Earnings Adjustment to adopt credit-loss guidance, net of tax	[1]	Retained Earnings Adoption, adjusted balance	Treasury Stock	Treasury Stock Adoption, adjusted balance
Balance (in shares) at Dec. 31, 2019								75,557	75,557
Beginning balance at Dec. 31, 2019		$ 460,305	[1]	$ (32,099)		$ 428,206		$ 756	$ 756	$ 270,614	$ 270,614	$ 2,919	$ 2,919	$ 195,455	$ (32,099)		$ 163,356	$ (9,439)	$ (9,439)
Comprehensive income:
Net income for the period		98,682	[1]											98,682
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes		2,644	[1]									2,644
Total comprehensive income	[1]	101,326
Exercise of stock options and other stock-based compensation, net of shares tendered for payment (in shares)								235
Exercise of stock options and other share-based compensation, net of shares tendered for payment		2,920	[1]					$ 2		2,918
Payment of statutory withholding on issuance of restricted stock units		(675)	[1]							(675)
Share-based expense		7,329	[1]							7,329
Treasury shares issued for Deferred Compensation Plan funding		385	[1]							438								(53)
Shares issued pursuant to Employee Stock Plan		1,835	[1]							1,329								506
Dividends paid and accrued		(61,145)	[1]											(61,145)
Shares issued pursuant to Dividend Reinvestment Plan		93	[1]							66								27
Other (in shares)								6
Other		187	[1]							187
Balance (in shares) at Dec. 31, 2020								75,798
Ending balance at Dec. 31, 2020		480,461	[1]					$ 758		282,206		5,563		200,893				(8,959)
Comprehensive income:
Net income for the period		45,863	[1]											45,863
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes		(1,563)	[1]									(1,563)
Total comprehensive income	[1]	44,300
Exercise of stock options and other stock-based compensation, net of shares tendered for payment (in shares)								207
Exercise of stock options and other share-based compensation, net of shares tendered for payment		2,425	[1]					$ 2		2,423
Payment of statutory withholding on issuance of restricted stock units		(1,410)	[1]							(1,410)
Share-based expense		8,600	[1]							8,600
Purchases of treasury stock		(21,535)	[1]															(21,535)
Treasury shares issued for Deferred Compensation Plan funding		368	[1]							574								(206)
Shares issued pursuant to Employee Stock Plan		2,052	[1]							1,554								498
Dividends paid and accrued		(62,799)	[1]											(62,799)
Shares issued pursuant to Dividend Reinvestment Plan		92	[1]							54								38
Other (in shares)								4
Other		$ 123	[1]							123
Balance (in shares) at Dec. 31, 2021		73,769						76,009
Ending balance at Dec. 31, 2021		$ 452,677	[1]					$ 760		294,124		4,000		183,957				(30,164)
Comprehensive income:
Net income for the period		34,630	[1]											34,630
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes		(7,477)	[1]									(7,477)
Total comprehensive income	[1]	27,153
Exercise of stock options and other stock-based compensation, net of shares tendered for payment (in shares)								148
Exercise of stock options and other share-based compensation, net of shares tendered for payment		410	[1]					$ 2		408
Payment of statutory withholding on issuance of restricted stock units		(1,071)	[1]							(1,071)
Share-based expense		9,044	[1]							9,044
Purchases of treasury stock		0
Treasury shares issued for Deferred Compensation Plan funding		374	[1]							(634)								1,008
Shares issued pursuant to Employee Stock Plan		1,512	[1]							368								1,144
Dividends paid and accrued		(64,092)	[1]											(64,092)
Shares issued pursuant to Dividend Reinvestment Plan		106	[1]							6								100
Other (in shares)								4
Other		$ 59	[1]							59
Balance (in shares) at Dec. 31, 2022		74,088						76,161
Ending balance at Dec. 31, 2022		$ 426,172	[1]					$ 762		$ 302,304		$ (3,477)		$ 154,495				$ (27,912)
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Accounting Standards Update [Extensible List]				Accounting Standards Update 2016-13 [Member]
Cash dividend paid per common share (in dollars per share)	$ 0.86	$ 0.84	$ 0.82

Description of Business and Sig

Description of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Description of Business and Significant Accounting Policies	Note 1 — Description of Business and Significant Accounting Policies Nature of Operations Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs. The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”). Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility. Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs. Principles of Consolidation The financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and with the rules and regulations of the SEC, specifically Regulation S-X and the instructions to Form 10-K. Unless otherwise indicated, all references to years are to the Company’s fiscal year, which ends on December 31. The accompanying Consolidated Financial Statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Use of Estimates in Financial Statements In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes. Fair Value of Financial Instruments The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs (Levels 1 and 2) and minimize the use of unobservable inputs (Level 3) within the fair value hierarchy. Assets and liabilities are classified within the fair value hierarchy based on the lowest level (least observable) input that is significant to the measurement in its entirety. While unobservable inputs reflect the Company’s market assumptions, preference is given to observable inputs. These two types of inputs create the following fair value hierarchy: Level 1 – Quoted prices for identical instruments in active markets; Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3 – Significant inputs to the valuation model are unobservable The Company’s financial instruments that are measured at fair value on a recurring basis consist of marketable securities and the deferred compensation fund investments. Other financial instruments such as cash and cash equivalents, accounts and notes receivable, accounts payable (including income taxes payable and accrued expenses) and borrowings under the Company’s line of credit are short-term in nature, and therefore the carrying value of these instruments are deemed to approximate their fair value. See Note 6 — Fair Value Measurements for the fair value hierarchy table and for details on the measurement of fair value for assets and liabilities. Cash and Cash Equivalents Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk. The Company currently has bank deposits with financial institutions in the U.S. that exceed FDIC insurance limits. Investments in Marketable Securities Marketable securities are defined as fixed income investments which are highly liquid and can be readily purchased or sold through established markets. As of December 31, 2022 and 2021, the Company had marketable securities of $95.2 million and $114.4 million, respectively, comprised primarily of tax-exempt municipal bonds. These investments are accounted for as available-for-sale securities and are reported at fair value on the Company's Consolidated Balance Sheets. For the years ended December 31, 2022 and 2021, $7.5 million and $1.6 million of unrealized losses related to these investments were recorded in other comprehensive income, respectively. For the year ended December 31, 2020, $2.6 million of unrealized gains related to these marketable securities were recorded in other comprehensive income. Unrealized gains and losses are recorded net of income taxes. These assets are available for future needs under the Company’s self-insurance programs and are held by the Company’s wholly-owned captive insurance company subsidiary as required by state insurance regulations. The Company’s investment policy is intended to manage the assets to achieve the goals of preserving principal, maintaining adequate liquidity at all times, and maximizing returns subject to investment guidelines. The investment policy limits investment to certain types of instruments issued by institutions primarily with investment grade credit ratings and places restrictions on concentration by type and issuer. The Company periodically reviews the investments in marketable securities for credit impairment when an investment’s fair value declines below the amortized cost basis and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. As of December 31, 2022, management believes that the recorded value of the Company’s investments in marketable securities was recoverable in all material respects. See Note 6 — Fair Value Measurements for credit impairment considerations. Accounts and Notes Receivable Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided. Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 4 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit losses. Refer to Note 7 — Accounts and Notes Receivable herein for further information. Allowance for Doubtful Accounts The Company estimates the allowance for doubtful accounts using an expected loss model prepared in accordance with the FASB Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). ASC 326 requires the Company to estimate the lifetime expected credit losses on accounts receivable and notes receivable and to record an allowance to offset the receivables at the time when the transactions are recorded. Modeling is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Refer to Note 8 — Allowance for Doubtful Accounts herein for further information. Inventories and Supplies Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months. Revenue Recognition The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services. Refer to Note 2 — Revenue herein for further information. Leases The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, as permitted by U.S. GAAP. A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of the years ended December 31, 2022 and 2021, the Company was only the lessee of operating lease arrangements. Refer to Note 9 — Lease Commitments herein for further information. Property and Equipment, Net Property and equipment, with the exception of those pertaining to leases, are stated at cost, net of accumulated depreciation. Additions, renewals and improvements are capitalized, while maintenance and repair costs are expensed when incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in income. Depreciation is recorded using the straight-line method over the following estimated useful lives: Housekeeping and Dietary equipment — 3 to 5 years; computer hardware and software — 3 to 5 years; and other, consisting of furniture and fixtures, leasehold improvements and vehicles — 5 to 10 years. Depreciation expense on property and equipment for the years ended December 31, 2022, 2021 and 2020 was $10.5 million, $10.3 million and $10.1 million, respectively. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not. Deferred tax assets and liabilities are more fully described in Note 12 — Income Taxes. Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s Consolidated Financial Statements based on a recognition and measurement process. The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal and immaterial to its financial results. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense. Earnings per Common Share Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock and restricted stock units. Share-Based Compensation The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur. Advertising Costs Advertising costs are expensed when incurred. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020. Impairment of Long-Lived Assets The carrying amounts of long-lived assets are periodically reviewed to determine whether current events or circumstances warrant adjustment to such carrying amounts. Any impairment would be measured as the amount that the carrying value of such assets exceeds their fair value, primarily based on estimated undiscounted cash flows. Considerable management judgment is necessary to estimate the fair value of assets. Assets to be disposed of are carried at the lower of their financial statement carrying amount or fair value, less cost to sell. No impairment loss was recognized on the Company’s long-lived assets during the years ended December 31, 2022, 2021 or 2020. Identifiable Intangible Assets and Goodwill Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment on a reporting unit basis, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value. No impairment loss was recognized on the Company's intangible assets or goodwill during the years ended December 31, 2022, 2021 or 2020. Treasury Stock Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid-in capital. Concentrations of Credit Risk The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At December 31, 2022 and 2021, the majority of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance. Although the Company negotiates the pricing and other terms for the majority of our purchases of food and dining supplies directly with national manufacturers, the Company procures more than 50% of these products and other items through Sysco Corporation (“Sysco”). Sysco, is responsible for tracking our orders and delivering products to our specific locations. Significant Customers For the years ended December 31, 2022, 2021 and 2020, Genesis Healthcare, Inc. (“Genesis”) accounted for $169.1 million or 10.0%, $177.1 million or 10.8% and $258.7 million or 14.7% of the Company’s consolidated revenues, respectively. Genesis commenced a restructuring effort in 2020 that continued in 2022. As part of Genesis’ restructuring effort, during 2021, the Company and Genesis reached an agreement in principle to modify pricing through December 2021 (at which time the original pricing terms resumed) and payment terms through December 2022, at which point the original payment terms would resume. The agreement was executed in 2022. Genesis remains largely compliant with the terms of the agreement as the parties continue discussions regarding a long-term contract structure. As of December 31, 2022, the Company had outstanding accounts receivable and notes receivable of $36.2 million and $20.4 million, respectively, from Genesis. Although the Company expects to continue its relationship with Genesis, there can be no assurance thereof. Revenues generated from Genesis were included in both operating segments previously mentioned. Any extended discontinuance of revenues, or significant reduction, from this customer could, if not replaced, have a material impact on our operations. In addition, if Genesis fails to abide by current payment terms it could increase our accounts receivable balance and have a material adverse effect on our financial condition, results of operations, and cash flows. No other single customer or customer group represented more than 10% of consolidated revenues for the years ended December 31, 2022, 2021 and 2020. Recent Accounting Pronouncements There have been no new accounting pronouncements that have significance, or potential significance, to our Consolidated Financial Statements.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Note 2 — Revenue The Company presents its consolidated revenues disaggregated by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 14 — Segment Information herein as well as the information below regarding the Company’s reportable segments. Housekeeping Housekeeping accounted for $795.7 million, $821.3 million and $895.3 million of the Company’s consolidated revenues for the years ended December 31, 2022, 2021 and 2020, respectively. The Housekeeping services include managing customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation. Dietary Dietary services accounted for $894.5 million, $820.6 million and $865.0 million of the Company’s consolidated revenues for the years ended December 31, 2022, 2021 and 2020, respectively. Dietary services consist of managing customers’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to customers. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation. Revenue Recognition The Company’s revenues are derived from contracts with customers. The Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company is entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material. The Company performs services and provides goods in accordance with its contracts with its customers. Such contracts typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice, after an initial period of 60 to 120 days. A performance obligation is the unit of account under ASC 606 and is defined as a promise in a contract to transfer a distinct good or service to the customer. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services that are substantially the same and that have the same pattern of transfer to the customer. The Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the customers’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was $0.3 million and $0.1 million as of December 31, 2022 and 2021. Additionally, substantially all such revenue amounts deferred as of December 31, 2021 were subsequently recognized as revenue during the year ended December 31, 2022. The transaction price is the amount of consideration to which the Company is entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when the Company determines that there will not be a significant reversal in the amount of revenue recognized. During the year ended December 31, 2022 the Company recognized a $10.0 million reduction to revenues related to a contract modification. The Company’s contracts generally do not contain significant financing components, as payment terms are less than one year. The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represents a single performance obligation that is satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. As of December 31, 2022 and 2021, the value of the contract liabilities associated with customer prepayments was $3.1 million and $2.5 million , respectively. Additionally, all such revenue amounts deferred as of December 31, 2021 were subsequently recognized as revenue during the year ended December 31, 2022. Transaction Price Allocated to Remaining Performance Obligations The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. At December 31, 2022, the Company had $120.3 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 85.7% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consists of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Income by Component	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Changes in Accumulated Other Comprehensive Income by Component	Note 3 — Changes in Accumulated Other Comprehensive Income by Component For the years ended December 31, 2022, 2021 and 2020, the Company’s accumulated other comprehensive income consisted of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following tables provide a summary of the changes in accumulated other comprehensive income, net of taxes: Unrealized Gains and (Losses) on Available-for-Sale Securities 1 Year Ended December 31, 2022 2021 2020 (in thousands) Accumulated other comprehensive income — beginning balance $ 4,000 $ 5,563 $ 2,919 Other comprehensive (loss) income before reclassifications (7,505) (1,522) 2,557 Losses (gains) reclassified from other comprehensive income 2 28 (41) 87 Net current period other comprehensive (loss) income 3 (7,477) (1,563) 2,644 Accumulated other comprehensive income — ending balance $ (3,477) $ 4,000 $ 5,563 1. All amounts are net of tax. 2. Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the year ended December 31, 2022, the Company recorded less than $0.1 million of realized losses from the sale of available-for-sale securities. For the year ended December 31, 2021, the Company recorded $0.1 million of realized gains from the sale of available-for-sale securities. For the year ended December 31, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 6 — Fair Value Measurements herein for further information. 3. For the year ended December 31, 2022, the change in other comprehensive income was net of a tax benefit of $2.0 million. For the years ended December 31, 2021 and 2020, the changes in other comprehensive income were net of a tax benefit of $0.4 million and expense of $0.7 million, respectively. Amounts Reclassified from Accumulated Other Comprehensive Income 2022 2021 2020 (in thousands) Year Ended December 31, (Losses) gains from the sale of available-for-sale securities $ (37) $ 55 $ (114) Tax (expense) benefit 9 (14) 27 Net (loss) gain reclassified from accumulated other comprehensive income $ (28) $ 41 $ (87)

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Note 4 — Property and Equipment, Net Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred. The following table sets forth the amounts of property and equipment by each class of depreciable asset as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (in thousands) Housekeeping and Dietary equipment $ 13,585 $ 13,468 Computer hardware and software 6,086 5,880 Operating lease — right-of-use assets 34,445 33,217 Other 1 1,055 1,736 Total property and equipment, at cost 55,171 54,301 Less accumulated depreciation 32,196 26,199 Total property and equipment, net $ 22,975 $ 28,102 1. Includes furniture and fixtures, leasehold improvements and autos and trucks. Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $10.5 million, $10.3 million, and $10.1 million, respectively. Of the depreciation expense recorded for the years ended December 31, 2022, 2021 and 2020 $6.1 million, $6.4 million and $5.6 million related to the depreciation of the Company’s operating lease - right-of-use assets (“ROU Assets”), respectively.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 5 — Goodwill and Other Intangible Assets Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets of acquired businesses. Goodwill is not amortized but is evaluated for impairment on an annual basis or more frequently if impairment indicators arise. To date, the Company has not recognized an impairment of its goodwill. The following table sets forth the amounts of goodwill by reportable segment, as described in Note 14 — Segment Information, as of December 31, 2022 and 2021: December 31, 2021 Acquisitions 1 December 31, 2022 (in thousands) Housekeeping $ 42,377 $ — $ 42,377 Dietary 32,378 774 33,152 Total Goodwill $ 74,755 $ 774 $ 75,529 1. During the year ended December 31, 2022, the Company’s goodwill increased $0.7 million due to a measurement period adjustment pertaining to a prior period acquisition. The Company finalized the acquisition accounting for this transaction in 2022. Intangible Assets The Company’s other intangible assets were obtained through acquisitions and are recorded at their fair values at the date of acquisition. The following table sets forth the amounts of other intangible assets as of December 31, 2022 and 2021: December 31, 2022 December 31, 2021 Gross Amount Accumulated Amortization Net Amount Gross Amount Accumulated Amortization Net Amount (in thousands) Customer relationships $ 45,634 $ 32,211 $ 13,423 $ 45,634 $ 27,704 $ 17,930 Trade names 1,731 191 1,540 1,731 55 1,676 Patents 1,086 232 854 1,086 95 991 Non-compete agreements 233 104 129 233 25 208 Total other intangible assets $ 48,684 $ 32,738 $ 15,946 $ 48,684 $ 27,879 $ 20,805 No acquisitions occurred during the year ended December 31, 2022. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives. The weighted-average amortization period of customer relationships, trade names, patents, and non-compete agreements are approximately 10 years, 13 years, 8 years, and 4 years, respectively. The following table sets forth the estimated amortization expense for intangibles subject to amortization for 2023, the following four fiscal years and thereafter: Period/Year Total Amortization Expense (in thousands) 2023 $ 3,819 2024 $ 2,685 2025 $ 2,685 2026 $ 2,666 2027 $ 1,196 Thereafter $ 2,895 Total $ 15,946 Amortization expense for the years ended December 31, 2022, 2021, and 2020 was $4.9 million, $4.4 million and $4.2 million, respectively.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6 — Fair Value Measurements The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities and inventories) are recorded at cost in the Company’s Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations. Inventories are measured at the lower of cost or net realizable value. The Company’s marketable securities primarily consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in other comprehensive income (net of tax) within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the year ended December 31, 2022, the Company recorded unrealized losses, net of taxes of $7.5 million on marketable securities. For the years ended December 31, 2021 and 2020, the Company recorded unrealized losses, net of taxes of $1.6 million and unrealized gains, net of taxes of $2.6 million on marketable securities, respectively. For the years ended December 31, 2022, 2021 and 2020, the Company received total proceeds, less the amount of interest received, of $10.4 million, $26.7 million and $6.3 million, respectively, from sales of available-for-sale municipal bonds. For both years ended December 31, 2022 and 2020, these sales each resulted in realized losses of less than $0.1 million, and realized gains of $0.1 million for the year ended December 31, 2021. Such gains and losses were recorded in “Investment and other income, net” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period. The investments under the funded deferred compensation plan are accounted for as trading securities and unrealized gains or losses are included in earnings. The fair value of these investments, excluding amounts held in money market accounts, is determined based on quoted market prices (Level 1). The fair value of money market accounts is measured using quoted prices for identical or similar instruments in markets that are not active (Level 2). For the years ended December 31, 2022, 2021 and 2020, the Company recognized unrealized losses of $9.3 million and gains of $6.5 million and $9.5 million, respectively, related to equity securities still held at the respective reporting dates. As part of a 2021 acquisition of a prepackaged meal manufacturer, the Company agreed to pay royalties to the seller on all future product sales. The Company recorded a liability of $10.6 million as of the acquisition date in 2021 for the expected future payments within "Other long-term liabilities" on the Consolidated Balance Sheets. The fair value of this liability is measured using forecasted sales models (Level 3). For the years ended December 31, 2022 and 2021, the Company recorded realized gains of $2.4 million and $0.1 million, respectively, within "Cost of services provided" in the Consolidated Statements of Comprehensive Income related to the subsequent measurement of the liability at each period end. The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of December 31, 2022 and December 31, 2021: As of December 31, 2022 Fair Value Measurement Using: Carrying Amount Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in thousands) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 95,200 $ 95,200 $ — $ 95,200 $ — Deferred compensation fund Money Market 1 $ 2,420 $ 2,420 $ — $ 2,420 $ — Commodities 170 170 170 — — Fixed Income 3,571 3,571 3,571 — — International 4,093 4,093 4,093 — — Large Cap Blend 1,210 1,210 1,210 — — Large Cap Growth 11,064 11,064 11,064 — — Large Cap Value 6,133 6,133 6,133 — — Mid Cap Blend 2,667 2,667 2,667 — — Real Estate 359 359 359 — — Small Cap Blend 3,424 3,424 3,424 — — Deferred compensation fund 2 $ 35,111 $ 35,111 $ 32,691 $ 2,420 $ — As of December 31, 2021 Fair Value Measurement Using: Carrying Total Fair Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in thousands) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 114,396 $ 114,396 $ — $ 114,396 $ — Deferred compensation fund Money Market 1 $ 2,882 $ 2,882 $ — $ 2,882 $ — Balanced and Lifestyle 12,578 12,578 12,578 — — Large Cap Growth 20,358 20,358 20,358 — — Small Cap Growth 6,561 6,561 6,561 — — Fixed Income 4,826 4,826 4,826 — — International 2,299 2,299 2,299 — — Mid Cap Growth 4,179 4,179 4,179 — — Deferred compensation fund $ 53,683 $ 53,683 $ 50,801 $ 2,882 $ — 1. The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment. 2. The deferred compensation fund carrying amounts and total fair value amounts as of December 31, 2022 and 2021 are inclusive of $1.6 million and $7.0 million of holdings expected to be paid to former employees within the next twelve months and were recorded under “Prepaid expenses and other assets” in the Company’s Consolidated Balance Sheets. Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Other-than-temporary Impairments (in thousands) December 31, 2022 Type of security: Municipal bonds — available-for-sale $ 99,601 $ 229 $ (4,630) $ 95,200 $ — Total debt securities $ 99,601 $ 229 $ (4,630) $ 95,200 $ — December 31, 2021 Type of security: Municipal bonds — available-for-sale $ 109,331 $ 5,219 $ (154) $ 114,396 $ — Total debt securities $ 109,331 $ 5,219 $ (154) $ 114,396 $ — December 31, 2020 Type of security: Municipal bonds — available-for-sale $ 117,970 $ 7,043 $ (1) $ 125,012 $ — Total debt securities $ 117,970 $ 7,043 $ (1) $ 125,012 $ — The following table summarizes the contractual maturities of debt securities held at December 31, 2022 and December 31, 2021, which are classified as marketable securities in the Company’s Consolidated Balance Sheets: Municipal Bonds — Available-for-Sale Contractual maturity: December 31, 2022 December 31, 2021 (in thousands) Maturing in one year or less $ 2,798 $ 5,606 Maturing in second year through fifth year 35,068 23,054 Maturing in sixth year through tenth year 38,575 52,180 Maturing after ten years 18,759 33,556 Total debt securities $ 95,200 $ 114,396

Accounts and Notes Receivable

Accounts and Notes Receivable	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Accounts and Notes Receivable	Note 7 — Accounts and Notes Receivable The Company’s accounts and notes receivable balances consisted of the following as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (in thousands) Short-term Accounts and notes receivable $ 406,969 $ 352,659 Allowance for doubtful accounts (70,192) (59,271) Total net short-term accounts and notes receivable $ 336,777 $ 293,388 Long-term Notes receivable $ 35,882 $ 35,571 Allowance for doubtful accounts (3,273) (6,312) Total net long-term notes receivable $ 32,609 $ 29,259 Total net accounts and notes receivable $ 369,386 $ 322,647 The Company makes credit decisions on a case-by-case basis after reviewing a number of qualitative and quantitative factors related to the specific customer as well as current industry variables that may impact that customer. There are a variety of factors that impact a customer’s ability to pay in accordance with the Company’s contracts. These factors include, but are not limited to, fluctuating census numbers, litigation costs and the customer’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the customer’s cash flows and its ability to make timely payments. However, the customer’s obligation to pay the Company in accordance with the contracts are not contingent upon the customer’s cash flow. Notwithstanding the Company’s efforts to minimize its credit risk exposure, the aforementioned factors, as well as other factors that impact customer cash flows or ability to make timely payments, could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition. Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition, modification or termination of customer relationships. The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes to enhance the collectability of amounts due, by instituting definitive repayment plans and providing a means by which to further evidence the amounts owed. In addition, the Company may amend contracts from full service to management-only arrangements, or adjust contractual payment terms, to accommodate customers who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Allowance for Doubtful Accounts	Note 8 — Allowance for Doubtful Accounts On January 1, 2020 (the “adoption date”), the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate future expected credit losses on such instruments before an impairment may occur. On the adoption date, the Company recorded an initial increase of $42.2 million to the Company’s allowance for doubtful accounts, with an offset recorded as an opening adjustment to retained earnings. In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition. The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a triggering event such as bankruptcy. At the end of each period the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable. The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established considering the environment of the long-term care industry and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. For the years ended December 31, 2022, 2021 and 2020, the Company recognized $1.1 million, $1.2 million and $1.7 million in interest income from notes receivables, respectively. The following table presents the Company’s two tiers of notes receivable for the years ended December 31, 2022 and 2021, respectively, further disaggregated by year of origination, as well as write-off activity: Notes Receivable as of December 31, 2022 Amortized Cost Basis by Origination Year 2022 2021 2020 2019 2018 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 31,406 $ 10,887 $ 1,683 $ 208 $ 13 $ 21,982 $ 66,179 Elevated risk notes receivable $ — $ — $ — $ — $ — $ 1,223 $ 1,223 Current-period gross write-offs $ 1 $ — $ 51 $ 54 $ — $ 491 $ 597 Current-period recoveries — — — — — — — Current-period net write-offs $ 1 $ — $ 51 $ 54 $ — $ 491 $ 597 Notes Receivable as of December 31, 2021 Amortized Cost Basis by Origination Year 2021 2020 2019 2018 2017 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 16,558 $ 6,862 $ 401 $ 18,738 $ 21,288 $ 1,560 $ 65,407 Elevated risk notes receivable $ — $ — $ — $ — $ 406 $ 1,374 $ 1,780 Current-period gross write-offs $ — $ — $ 541 $ 489 $ 2,494 $ — $ 3,524 Current-period recoveries — — (1) — — (38) (39) Current-period net write-offs $ — $ — $ 540 $ 489 $ 2,494 $ (38) $ 3,485 The following table provides information as to the status of payment on the Company’s gross notes receivable which were past due as of December 31, 2022 and 2021, respectively: Age Analysis of Past-Due Notes Receivable as of December 31, 2022 0-90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 894 $ 263 $ 3,330 $ 4,487 Elevated risk notes receivable — — 1,223 1,223 $ 894 $ 263 $ 4,553 $ 5,710 Age Analysis of Past-Due Notes Receivable as of December 31, 2021 0-90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 953 $ 5,676 $ 6,536 $ 13,165 Elevated risk notes receivable — — 1,780 1,780 $ 953 $ 5,676 $ 8,316 $ 14,945 The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the years ended December 31, 2022 and 2021, respectively: Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 50,794 $ (16,825) $ 32,632 $ 66,601 Notes receivable Standard notes receivable $ 13,607 $ (6,783) $ (772) $ 6,052 Elevated risk notes receivable 1,183 (481) 109 811 Total notes receivable $ 14,790 $ (7,264) $ (663) $ 6,863 Total accounts and notes receivable $ 65,584 $ (24,089) $ 31,969 $ 73,464 1. Write-offs are shown net of recoveries. During the year ended December 31, 2022, the Company collected $0.3 million of accounts receivables that were recovered subsequent to being written-off. Adjustments include a reduction of $8.0 million of allowance for doubtful accounts which related to a contract modification during the year ended December 31, 2022. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 51,052 $ (9,215) $ 8,957 $ 50,794 Notes receivable Standard notes receivable $ 13,258 $ (183) $ 532 $ 13,607 Elevated risk notes receivable 3,491 (3,302) 994 1,183 Total notes receivable $ 16,749 $ (3,485) $ 1,526 $ 14,790 Total accounts and notes receivable $ 67,801 $ (12,700) $ 10,483 $ 65,584 1. Write-offs are shown net of recoveries. During the year ended December 31, 2021, the Company collected $0.2 million of accounts receivables that were recovered subsequent to being written-off.

Lease Commitments

Lease Commitments	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lease Commitments	Note 9 — Lease Commitments The Company recognizes ROU Assets and Lease Liabilities for automobiles, office buildings, IT equipment, and small storage units for the temporary storage of operational equipment. The Company’s leases have remaining lease terms ranging from less than 1 year to 7 years, and have extension options ranging from 1 year to 5 years. Most leases include the option to terminate the lease within 1 year. Upon adopting ASC 842, the Company made accounting policy elections using practical expedients offered under the guidance to combine lease and non-lease components within leasing arrangements and to recognize the payments associated with short-term leases in earnings on a straight-line basis over the lease term, with the cost associated with variable lease payments recognized when incurred. These accounting policy elections impact the value of the Company’s ROU Assets and Lease Liabilities. The value of the Company’s ROU Assets is determined as the non-depreciated fair value of its leasing arrangements and is recorded to Property and Equipment, net on the Company’s Consolidated Balance Sheets. The value of the Company’s Lease Liabilities is the present value of fixed lease payments not yet paid, discounted using either the rate implicit in the lease contract if that rate can be determined, or the Company’s incremental borrowing rate (“IBR”). As of December 31, 2022 and 2021, the Company’s short-term portion of lease obligations were $5.3 million and $6.5 million, respectively, and are recorded in Other accrued expenses Components of lease expense are presented below for the years ended December 31, 2022, 2021 and 2020. Year Ended December 31, 2022 2021 2020 (in thousands) Lease cost Operating lease cost $ 5,673 $ 6,210 $ 5,381 Short-term lease cost 1,265 747 738 Variable lease cost 857 973 464 Total lease cost $ 7,795 $ 7,930 $ 6,583 Supplemental information is presented below for the years ended December 31, 2022, 2021 and 2020. Year Ended December 31, 2022 2021 2020 (dollar amounts in thousands) Other information Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 6,385 $ 6,609 $ 5,690 ROU Assets obtained in exchange for lease obligations $ 1,650 7,143 5,410 Weighted-average remaining lease term — operating leases 4.2 years 4.5 years 5.4 years Weighted-average discount rate — operating leases 4.4 % 4.2 % 4.5 % During the years ended December 31, 2022 and 2021, the Company’s ROU Assets and Lease Liabilities were reduced by $1.7 million and $0.8 million, respectively due to lease cancellations. The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of December 31, 2022: Period/Year Operating Leases (in thousands) 2023 $ 5,267 2024 3,502 2025 1,714 2026 1,337 2027 1,363 Thereafter 1,505 Total minimum lease payments $ 14,688 Less: imputed lease payments 1,317 Present value of lease liabilities $ 13,371

Share-Based Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Note 10 — Share-Based Compensation The components of the Company’s share-based compensation expense for the years ended December 31, 2022, 2021 and 2020 are as follows: Year Ended December 31, 2022 2021 2020 (in thousands) Stock options $ 1,253 $ 1,832 $ 2,134 Restricted stock, restricted stock units and deferred stock units 6,972 6,367 5,195 Performance stock units 819 401 — Employee Stock Purchase Plan 170 227 543 Total pre-tax share-based compensation expense charged against income $ 9,214 $ 8,827 $ 7,872 Total recognized tax deficiency related to share-based compensation $ (783) $ (217) $ (293) The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive Income for the years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands) Selling, general & administrative expense $ 9,160 $ 8,767 $ 7,718 Costs of services provided 54 60 154 Total $ 9,214 $ 8,827 $ 7,872 At December 31, 2022 and 2021, the unrecognized compensation cost related to unvested stock options and awards was $15.8 million and $17.5 million, respectively. The weighted average period over which these awards will vest was approximately 2.8 years as of December 31, 2022 and 2.6 years as of December 31, 2021. 2020 Omnibus Incentive Plan On May 26, 2020, the Company adopted the 2020 Omnibus Incentive Plan (the “2020 Plan”) after approval by the Company’s shareholders. The 2020 Plan provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, performance stock units, restricted stock units and other stock awards. The 2020 Plan seeks to encourage profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company’s operating objectives. As of December 31, 2022, there were 4.7 million shares of common stock reserved for issuance under the 2020 Plan, of which, 1.4 million are available for future grant. The amount of shares available for issuance under the 2020 Plan will increase when outstanding awards under the Company’s Second Amended and Restated 2012 Equity Incentive Plan (the “2012 Plan”) are subsequently forfeited, terminated, lapsed, or satisfied thereunder in cash or property other than shares. No stock award will have a term in excess of 10 years. The Nominating, Compensation and Stock Option Committee (the “NCSO”) of the Board of Directors is responsible for determining the terms of the grants in accordance with the 2020 Plan. Stock Options A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2022 and changes during 2022 are as follows: Stock Options Outstanding Number of Shares Weighted Average Exercise Price (in thousands) December 31, 2021 2,181 $ 33.42 Granted 352 $ 18.10 Exercised (23) $ 17.50 Forfeited — $ — Expired (135) $ 28.99 December 31, 2022 2,375 $ 31.56 The weighted average grant-date fair value of stock options granted during the years ended December 31, 2022, 2021, and 2020 was $4.06, $7.01 and $4.66 per common share, respectively. The total intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 was $0.1 million, $0.7 million and $1.3 million, respectively. The total fair value of stock options vested during the years ended December 31, 2022, 2021 and 2020 were $1.8 million, $2.1 million and $2.6 million, respectively. For the years ended December 31, 2022 and 2021, the tax deficiency realized from stock options exercised was immaterial. For the year ended December 31, 2020, the tax benefit realized from stock options exercised was $0.1 million. The fair value of stock option awards granted in 2022, 2021 and 2020 were estimated on the dates of grant using the Black-Scholes option valuation model with the following assumptions: Year Ended December 31, 2022 2021 2020 Risk-free interest rate 1.5 % 0.6 % 1.8 % Weighted average expected life 6.7 years 6.6 years 6.6 years Expected volatility 36.6 % 34.7 % 26.5 % Dividend yield 4.6 % 2.9 % 3.2 % The following table summarizes other information about the stock options at December 31, 2022: December 31, 2022 (amounts in thousands, except per share data) Outstanding: Aggregate intrinsic value $ — Weighted average remaining contractual life 4.8 years Exercisable: Number of options 1,619 Weighted average exercise price $ 34.52 Aggregate intrinsic value $ — Weighted average remaining contractual life 3.3 years Restricted Stock Units The fair value of outstanding restricted stock units and restricted stock was determined based on the market price of the shares on the date of grant. During the years ended December 31, 2022, 2021 and 2020 the Company granted 0.4 million, 0.3 million, and 0.3 million restricted stock units with weighted average grant date fair values of $18.06, $28.53, and $24.43 per unit, respectively. During the years ended December 31, 2022, 2021 and 2020, the Company did not grant any restricted stock. A summary of the outstanding restricted stock units and restricted stock as of December 31, 2021 and changes during the year ended December 31, 2022 is as follows: Restricted Stock Units and Restricted Stock Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 652 $ 31.03 Granted 410 $ 18.06 Vested (184) $ 33.68 Forfeited (53) $ 25.25 December 31, 2022 825 $ 24.37 The weighted average remaining vesting period for the unvested restricted stock units and restricted stock is 2.9 years. The weighted average grant-date fair values and total fair values of restricted stock units and restricted stock vested during 2022, 2021 and 2020 were as follows: Year Ended December 31, 2022 2021 2020 (in thousands, except per share data) Weighted average grant-date fair value of restricted stock units granted $ 18.06 $ 28.53 $ 24.43 Total fair value of restricted stock units and restricted shares vested $ 3,307 $ 4,185 $ 2,287 Performance Stock Units On January 4, 2022, the NCSO granted 60,000 Performance Stock Units (“PSUs”) to the Company’s executive officers. Such PSUs are contingent upon the achievement of certain total shareholder return (“TSR”) targets as compared to the TSR of the S&P 400 MidCap Index and the participant’s continued employment with the Company for the three year period ending December 31, 2024, the date at which such awards vest. The unrecognized share-based compensation cost of the TSR-based PSU awards at December 31, 2022 is $1.2 million and is expected to be recognized over a weighted-average period of 1.8 years. A summary of the outstanding PSUs as of December 31, 2021 and changes during the year ended December 31, 2022 is as follows: Performance Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 35 $ 34.52 Granted 60 $ 21.00 Vested — $ — Forfeited — $ — December 31, 2022 95 $ 26.01 Deferred Stock Units On June 4, 2022, the NCSO granted an aggregate of 20,000 Deferred Stock Units (“DSUs”) to the Company’s non-employee directors. Each DSU award vests in one year. Once vested, the recipient shall be entitled to receive a lump sum payment of a number of shares equal to the total number of DSUs issued to such recipient upon the first to occur of (i) the five year anniversary of the date of grant, (ii) the recipient’s death, disability or separation of service from the Board, or (iii) a change of control (as defined by the 2020 Plan). The unrecognized share-based compensation cost of the DSU awards at December 31, 2022 is $0.1 million and is expected to be recognized over a weighted-average period of 0.4 years. Employee Stock Purchase Plan The Company’s Employee Stock Purchase Plan (“ESPP”) is currently available through 2026 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day. Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 1.9 million shares available for future grant at December 31, 2022. Under the terms of the ESPP, participants may contribute through payroll deductions up to $21,250 (85% of IRS limitation) of their compensation toward the purchase of the Company’s common stock. No employee may purchase common stock which exceeds $25,000 in fair market value (determined on the option date) for each calendar year. The option price per share is equal to the lower of 85% of the fair market price on the first day of the offering period, or 85% of the fair market price on the last day of the offering period. The following table summarizes information about the Company’s ESPP annual offerings for the years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands, except per share data) Common shares purchased 95 85 73 Per common share purchase price $ 10.20 $ 15.12 $ 20.67 The expense associated with the options granted under the ESPP during the year ended December 31, 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Year Ended December 31, 2022 2021 Risk-free interest rate 0.4% 0.1% Weighted average expected life (years) 1.0 1.0 Expected volatility 36.9% 61.7% Dividend yield 4.7% 2.9% Deferred Compensation Plan The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP is not qualified under Section 401 of the Internal Revenue Code. The SERP allows participants to defer up to 25% of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a 25% match of up to 15% of their earnings deferred in the form of the Company’s common stock based on the then-current market value. SERP participants fully vest in the Company’s matching contribution three years from the first day of the initial year of participation. The income deferred and the matching contributions are unsecured and subject to the claims of the Company’s general creditors. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.3 million shares available for future grant at December 31, 2022. At the time of issuance, such shares are accounted for at cost as treasury stock. At December 31, 2022, approximately 0.3 million of such shares are vested and remain in the respective active participants’ accounts with the trustee. The following table summarizes information about the SERP during the plan years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands) SERP expense 1 $ 486 $ 531 $ 512 Treasury shares issued to fund SERP expense 2 40 30 18 Year end SERP trust account balance 3 $ 35,111 $ 59,086 $ 54,729 Unrealized (loss) gain recorded in SERP liability account $ (9,178) $ 6,676 $ 9,200 1. Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income. 2. Shares related to the SERP match for each year are funded at the beginning of the subsequent year. 3. SERP trust account investments are recorded at their fair value which is based on quoted market prices. Differences between such amounts in the table above and the deferred compensation funding asset reported on the Company’s Consolidated Balance Sheets represent the value of Company common stock held in the Plan participants’ trust accounts and reported by the Company as treasury stock in the Company’s Consolidated Balance Sheets.

Other Employee Benefit Plans

Other Employee Benefit Plans	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
Other Employee Benefit Plans	Note 11 — Other Employee Benefit Plans Retirement Savings Plan Since October 1, 1999, the Company has had a retirement savings plan for eligible employees (the “RSP”) under Section 401(k) of the Internal Revenue Code. The RSP allows eligible employees to contribute up to 15% of their eligible compensation on a pre-tax basis.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 12 — Income Taxes The following table summarizes the provision for income taxes: Year Ended December 31, 2022 2021 2020 (amounts in thousands) Current: Federal $ 3,022 $ 9,120 $ 28,833 State 2,381 3,766 7,564 $ 5,403 $ 12,886 $ 36,397 Deferred: Federal $ 4,305 $ 2,118 $ (4,903) State 744 956 (990) $ 5,049 $ 3,074 $ (5,893) Tax provision $ 10,452 $ 15,960 $ 30,504 Deferred income taxes are recorded using the asset and liability method. Deferred tax assets and liabilities are determined based on differences between the financial reporting and income tax basis of assets and liabilities. Significant components of the Company’s federal and state deferred tax asset and liability balances were as follows: Year Ended December 31, 2022 2021 (in thousands) Deferred tax assets: Allowance for doubtful accounts $ 18,139 $ 16,124 Deferred compensation 8,686 9,587 Deferred payroll taxes under the CARES Act — 6,220 Accrued insurance claims 5,609 6,252 Non-deductible reserves 256 521 Leases 227 247 Other 2,488 1,854 $ 35,405 $ 40,805 Deferred tax liabilities: Expensing of housekeeping supplies $ (2,510) $ (3,085) Amortization of goodwill and intangibles (2,389) (2,118) Depreciation of property and equipment (1,769) (1,915) Other (399) (2,152) $ (7,067) $ (9,270) Net deferred tax assets $ 28,338 $ 31,535 Realization of the Company’s deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain. Management assesses the Company’s income tax positions and records tax benefits for all years subject to examination based upon an evaluation of the facts, circumstances, and information available at the reporting dates, which include historical operating results and expectations of future earnings. As such, management believes it is more likely than not that the deferred tax assets recorded will be realized to reduce future income taxes and therefore no valuation allowances are necessary. The table below provides a reconciliation between the tax expense computed by applying the statutory federal income tax rate to income before income taxes and the provision for income taxes: Year Ended December 31, 2022 2021 2020 (in thousands) Income tax expense computed at statutory rate $ 9,467 $ 12,983 $ 27,129 Increases (decreases) resulting from: State income taxes, net of federal tax benefit 2,625 3,931 4,985 Federal jobs credits (2,571) (3,177) (3,089) Tax exempt interest (308) (324) (323) Share-based compensation 1,250 1,072 1,323 Fines and penalties 1 4 1,294 20 Other, net (15) 181 459 Income tax expense $ 10,452 $ 15,960 $ 30,504 1. For the year ended December 31, 2020, the Company presented less than $0.1 million of fines and penalties within the Other, net caption. Such amounts have been reclassified to the Fines and penalties caption for comparative purposes.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 13 — Related Party Transactions For the years ended December 31, 2022, 2021 and 2020, the Company did not have any related party transactions.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	Note 14 — Segment Information The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve a similar customer base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete contracts, specific to each reportable segment. The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the Consolidated Financial Statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation. All revenues and net income are earned in the United States. Year Ended December 31, 2022 2021 2020 (in thousands) Revenues 1 Housekeeping $ 795,687 $ 821,329 $ 895,267 Dietary 894,489 820,630 865,036 Total $ 1,690,176 $ 1,641,959 $ 1,760,303 Income before income taxes Housekeeping $ 73,096 $ 79,380 $ 95,723 Dietary 29,065 45,758 68,293 Corporate 2 (57,079) (63,315) (34,830) Total $ 45,082 $ 61,823 $ 129,186 Depreciation and amortization Housekeeping $ 5,491 $ 5,399 $ 5,722 Dietary 3,075 2,611 2,394 Corporate 6,750 6,657 6,152 Consolidated $ 15,316 $ 14,667 $ 14,268 Total assets Housekeeping $ 250,444 $ 225,531 $ 214,500 Dietary 263,126 221,911 174,866 Corporate 3 204,764 330,087 395,665 Consolidated $ 718,334 $ 777,529 $ 785,031 Capital expenditures Housekeeping $ 4,412 $ 5,005 $ 3,710 Dietary 499 451 393 Corporate 299 231 238 Consolidated $ 5,210 $ 5,687 $ 4,341 1. For the years ended December 31, 2022 and 2021, both the Housekeeping and Dietary segments earned revenue from several significant customers, although Genesis was the only customer to contribute more than 10% of consolidated revenue. For the years ended December 31, 2022, 2021 and 2020, Genesis accounted for $169.1 million or 10.0%, $177.1 million or 10.8% and $258.7 million or 14.7% of the Company’s consolidated revenues, respectively. 2. Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense. 3. Primarily consists of cash and cash equivalents, marketable securities, deferred income taxes and other current and noncurrent assets.

Earnings Per Common Share

Earnings Per Common Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Common Share	Note 15 — Earnings Per Common Share Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options and unvested restricted stock and restricted stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding for 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 Numerator for basic and diluted earnings per share: Net income $ 34,630 $ 45,863 $ 98,682 Denominator: Weighted average number of common shares outstanding - basic 74,336 74,816 74,696 Effect of dilutive securities 1 15 146 89 Weighted average number of common shares outstanding - diluted 74,351 74,962 74,785 Basic earnings per share: $ 0.47 $ 0.61 $ 1.32 Diluted earnings per share: $ 0.47 $ 0.61 $ 1.32 1. Certain outstanding equity awards are anti-dilutive and therefore were excluded from the calculation of the weighted-average number of diluted common shares outstanding. Anti-dilutive outstanding equity awards under share-based compensation plans were as follows: Year Ended December 31, 2022 2021 2020 (in thousands) Anti-dilutive equity awards 3,203 1,980 2,121

Contractual Obligations and Oth

Contractual Obligations and Other Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contractual Obligations and Other Contingencies	Note 16 — Contractual Obligations and Other Contingencies Line of Credit At December 31, 2022, the Company had a $300 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a floating rate, based on the Company’s leverage ratio, and starting at Term Secured Overnight Financing Rate ("SOFR") plus 165 basis points. As of December 31, 2022, there were $25.0 million of borrowings under the line of credit. There were no borrowings under the line of credit as of December 31, 2021. The line of credit requires the Company to satisfy two financial covenants, with which the Company is in compliance as of December 31, 2022. The line of credit expires on November 22, 2027. The Company’s line of credit was amended on November 22, 2022 to, among other things, provide for a five-year unsecured revolving loan facility in the aggregate amount of $300 million with, at the Company’s option, the ability to increase the revolving loan commitments to an aggregate amount not to exceed $500 million and to change the benchmark rate from the London Interbank Offered Rate (“LIBOR”) to SOFR. At December 31, 2022, the Company also had outstanding $81.0 million in irrevocable standby letters of credit, which relate to payment obligations under the Company’s insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $81.0 million to $194.0 million at December 31, 2022. On November 25, 2022 and December 27, 2022, the letters of credit were renewed and expire on January 4, 2024. Tax Jurisdictions and Matters The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities. The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters. Legal Proceedings The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. As the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. If adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides financial disclosure, as appropriate. At this time, the Company is unable to reasonably estimate possible losses or form a judgment that an unfavorable outcome is either probable or remote with respect to certain pending litigation claims asserted and it is not currently possible to assess whether or not the outcome of these proceedings may have a material adverse effect on the Company. On October 15, 2021 the Company’s directors’ and officers’ liability insurance carriers paid a $16.8 million settlement to resolve a putative shareholder class action lawsuit originally filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania on March 22, 2019. Government Regulations The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care many of whom have been significantly impacted by COVID-19. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or additional changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate.

Accrued Insurance Claims

Accrued Insurance Claims	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued Insurance Claims	Note 17 — Accrued Insurance Claims The Company currently has a Paid Loss Retrospective Insurance Plan for general liability, workers’ compensation insurance and other self-insurance programs, which comprised approximately 30.4% and 27.5% of the Company’s liabilities at December 31, 2022 and 2021, respectively. Under the Company’s insurance plans, predetermined loss limits are arranged with the Company’s insurance company to limit both per occurrence cash outlay and annual insurance plan cost. The Company’s accounting for this plan utilizes current valuations from a third party actuary, which include assumptions based on data such as historical claims, pay-out experience, demographic factors, industry trends, severity factors, and other actuarial calculations. In the event that the Company’s claims experience and/or industry trends result in an unfavorable change in the assumptions or outcomes, it would have an adverse effect on the Company’s results of operations and financial condition. For general liability, workers’ compensation and other self-insurance programs, the Company records both a reserve for the estimated future cost of claims and related expenses that have been reported but not settled, as well as an estimate of claims incurred but not reported. General liability and workers’ compensation reserves for claims incurred but not reported are developed by a third party actuary through review of the Company’s historical data and open claims. In 2022, our self-insurance liabilities decreased due to a favorable $9.8 million adjustment after considering our updated actuarial estimates for projected incurred losses on past claims. Such estimates declined in 2022 due to favorable claim experience and loss mitigation efforts.

Treasury Stock

Treasury Stock	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Treasury Stock	Note 18 — Treasury StockFor the year ended December 31, 2022, the number of shares and value of shares repurchased were immaterial. During the year ended December 31, 2021, the Company’s Board of Directors authorized and the Company entered into a 10b5-1 plan (the “Plan”). The Plan was adopted under the safe harbor provided by rule 10b5-1and Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in order to assist the Company in implementing its share repurchase plans. Pursuant to the Company’s share repurchase program and as authorized by the Board of Directors on March 12, 2021, the Company purchased 1.0 million shares of the Company’s common stock during the year ended December 31, 2021 for a total cost of $21.5 million inclusive of transaction costs.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 19 — Subsequent Events The Company evaluated all subsequent events through the filing date of this Annual Report on Form 10-K. There were no events or transactions occurring during this subsequent reporting period which require recognition or additional disclosure in these financial statements.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts and Reserves	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts and Reserves	Schedule II — Valuation and Qualifying Accounts and Reserves Additions Description Beginning Balance Charged to Other Accounts (1) Charged to Costs and Expenses Deductions Ending Balance (in thousands) 2022 Allowance for Doubtful Accounts $ 65,583 $ — $ 31,969 $ 24,088 $ 73,464 2021 Allowance for Doubtful Accounts $ 67,801 $ — $ 10,483 $ 12,700 $ 65,583 2020 Allowance for Doubtful Accounts $ 52,393 $ 42,236 $ 9,636 $ 36,464 $ 67,801 1. All amounts charged to other accounts for the year ended December 31, 2020 pertain to the cumulative effect of the Company’s January 1, 2020 adoption of ASC 326 as described within Note 8 — Allowance for Doubtful Accounts.

Description of Business and S_2

Description of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Operations	Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs. The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”). Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility. Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.
Principles of Consolidation	The financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and with the rules and regulations of the SEC, specifically Regulation S-X and the instructions to Form 10-K. Unless otherwise indicated, all references to years are to the Company’s fiscal year, which ends on December 31. The accompanying Consolidated Financial Statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates in Financial Statements	In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.
Fair Value of Financial Instruments	The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs (Levels 1 and 2) and minimize the use of unobservable inputs (Level 3) within the fair value hierarchy. Assets and liabilities are classified within the fair value hierarchy based on the lowest level (least observable) input that is significant to the measurement in its entirety. While unobservable inputs reflect the Company’s market assumptions, preference is given to observable inputs. These two types of inputs create the following fair value hierarchy: Level 1 – Quoted prices for identical instruments in active markets; Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3 – Significant inputs to the valuation model are unobservable
Cash and Cash Equivalents	Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk. The Company currently has bank deposits with financial institutions in the U.S. that exceed FDIC insurance limits.
Investments in Marketable Securities	Marketable securities are defined as fixed income investments which are highly liquid and can be readily purchased or sold through established markets. As of December 31, 2022 and 2021, the Company had marketable securities of $95.2 million and $114.4 million, respectively, comprised primarily of tax-exempt municipal bonds. These investments are accounted for as available-for-sale securities and are reported at fair value on the Company's Consolidated Balance Sheets. For the years ended December 31, 2022 and 2021, $7.5 million and $1.6 million of unrealized losses related to these investments were recorded in other comprehensive income, respectively. For the year ended December 31, 2020, $2.6 million of unrealized gains related to these marketable securities were recorded in other comprehensive income. Unrealized gains and losses are recorded net of income taxes. These assets are available for future needs under the Company’s self-insurance programs and are held by the Company’s wholly-owned captive insurance company subsidiary as required by state insurance regulations. The Company’s investment policy is intended to manage the assets to achieve the goals of preserving principal, maintaining adequate liquidity at all times, and maximizing returns subject to investment guidelines. The investment policy limits investment to certain types of instruments issued by institutions primarily with investment grade credit ratings and places restrictions on concentration by type and issuer.
Accounts and Notes Receivable	Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided. Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 4 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit losses.
Allowance for Doubtful Accounts	The Company estimates the allowance for doubtful accounts using an expected loss model prepared in accordance with the FASB Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). ASC 326 requires the Company to estimate the lifetime expected credit losses on accounts receivable and notes receivable and to record an allowance to offset the receivables at the time when the transactions are recorded. Modeling is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses.
Inventories and Supplies	Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.
Revenue Recognition	The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services.
Leases	The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, as permitted by U.S. GAAP. A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of the years ended December 31, 2022 and 2021, the Company was only the lessee of operating lease arrangements.
Property and Equipment, Net	Property and equipment, with the exception of those pertaining to leases, are stated at cost, net of accumulated depreciation. Additions, renewals and improvements are capitalized, while maintenance and repair costs are expensed when incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in income. Depreciation is recorded using the straight-line method over the following estimated useful lives: Housekeeping and Dietary equipment — 3 to 5 years; computer hardware and software — 3 to 5 years; and other, consisting of furniture and fixtures, leasehold improvements and vehicles — 5 to 10 years.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not. Deferred tax assets and liabilities are more fully described in Note 12 — Income Taxes. Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s Consolidated Financial Statements based on a recognition and measurement process. The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal and immaterial to its financial results. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense.
Earnings per Common Share	Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock and restricted stock units.
Share-Based Compensation	The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.
Advertising Costs	Advertising costs are expensed when incurred.
Impairment of Long-Lived Assets	The carrying amounts of long-lived assets are periodically reviewed to determine whether current events or circumstances warrant adjustment to such carrying amounts. Any impairment would be measured as the amount that the carrying value of such assets exceeds their fair value, primarily based on estimated undiscounted cash flows. Considerable management judgment is necessary to estimate the fair value of assets. Assets to be disposed of are carried at the lower of their financial statement carrying amount or fair value, less cost to sell. No impairment loss was recognized on the Company’s long-lived assets during the years ended December 31, 2022, 2021 or 2020.
Identifiable Intangible Assets and Goodwill	Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment on a reporting unit basis, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value. No impairment loss was recognized on the Company's intangible assets or goodwill during the years ended December 31, 2022, 2021 or 2020.
Treasury Stock	Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid-in capital.
Concentrations of Credit Risk	The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At December 31, 2022 and 2021, the majority of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance. Although the Company negotiates the pricing and other terms for the majority of our purchases of food and dining supplies directly with national manufacturers, the Company procures more than 50% of these products and other items through Sysco Corporation (“Sysco”). Sysco, is responsible for tracking our orders and delivering products to our specific locations.
Significant Clients	Although the Company expects to continue its relationship with Genesis, there can be no assurance thereof. Revenues generated from Genesis were included in both operating segments previously mentioned. Any extended discontinuance of revenues, or significant reduction, from this customer could, if not replaced, have a material impact on our operations. In addition, if Genesis fails to abide by current payment terms it could increase our accounts receivable balance and have a material adverse effect on our financial condition, results of operations, and cash flows. No other single customer or customer group represented more than 10% of consolidated revenues for the years ended December 31, 2022, 2021 and 2020.
Recent Accounting Pronouncements	There have been no new accounting pronouncements that have significance, or potential significance, to our Consolidated Financial Statements.In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition.The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a triggering event such as bankruptcy. At the end of each period the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable.The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established considering the environment of the long-term care industry and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest.
Segment Information	The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the Consolidated Financial Statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

Description of Business and S_3

Description of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of Cumulative Effect of Initially Applying New Guidance

Changes in Accumulated Other _2

Changes in Accumulated Other Comprehensive Income by Component (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	The following tables provide a summary of the changes in accumulated other comprehensive income, net of taxes: Unrealized Gains and (Losses) on Available-for-Sale Securities 1 Year Ended December 31, 2022 2021 2020 (in thousands) Accumulated other comprehensive income — beginning balance $ 4,000 $ 5,563 $ 2,919 Other comprehensive (loss) income before reclassifications (7,505) (1,522) 2,557 Losses (gains) reclassified from other comprehensive income 2 28 (41) 87 Net current period other comprehensive (loss) income 3 (7,477) (1,563) 2,644 Accumulated other comprehensive income — ending balance $ (3,477) $ 4,000 $ 5,563 1. All amounts are net of tax. 2. Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the year ended December 31, 2022, the Company recorded less than $0.1 million of realized losses from the sale of available-for-sale securities. For the year ended December 31, 2021, the Company recorded $0.1 million of realized gains from the sale of available-for-sale securities. For the year ended December 31, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 6 — Fair Value Measurements herein for further information. 3. For the year ended December 31, 2022, the change in other comprehensive income was net of a tax benefit of $2.0 million. For the years ended December 31, 2021 and 2020, the changes in other comprehensive income were net of a tax benefit of $0.4 million and expense of $0.7 million, respectively.
Schedule of Reclassification out of Accumulated Other Comprehensive Income	Amounts Reclassified from Accumulated Other Comprehensive Income 2022 2021 2020 (in thousands) Year Ended December 31, (Losses) gains from the sale of available-for-sale securities $ (37) $ 55 $ (114) Tax (expense) benefit 9 (14) 27 Net (loss) gain reclassified from accumulated other comprehensive income $ (28) $ 41 $ (87)

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	The following table sets forth the amounts of property and equipment by each class of depreciable asset as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (in thousands) Housekeeping and Dietary equipment $ 13,585 $ 13,468 Computer hardware and software 6,086 5,880 Operating lease — right-of-use assets 34,445 33,217 Other 1 1,055 1,736 Total property and equipment, at cost 55,171 54,301 Less accumulated depreciation 32,196 26,199 Total property and equipment, net $ 22,975 $ 28,102 1. Includes furniture and fixtures, leasehold improvements and autos and trucks.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth the amounts of goodwill by reportable segment, as described in Note 14 — Segment Information, as of December 31, 2022 and 2021: December 31, 2021 Acquisitions 1 December 31, 2022 (in thousands) Housekeeping $ 42,377 $ — $ 42,377 Dietary 32,378 774 33,152 Total Goodwill $ 74,755 $ 774 $ 75,529
Schedule of Intangible Assets	The following table sets forth the amounts of other intangible assets as of December 31, 2022 and 2021: December 31, 2022 December 31, 2021 Gross Amount Accumulated Amortization Net Amount Gross Amount Accumulated Amortization Net Amount (in thousands) Customer relationships $ 45,634 $ 32,211 $ 13,423 $ 45,634 $ 27,704 $ 17,930 Trade names 1,731 191 1,540 1,731 55 1,676 Patents 1,086 232 854 1,086 95 991 Non-compete agreements 233 104 129 233 25 208 Total other intangible assets $ 48,684 $ 32,738 $ 15,946 $ 48,684 $ 27,879 $ 20,805
Schedule of Estimated Amortization Expense For Intangibles Subject To Amortization	The following table sets forth the estimated amortization expense for intangibles subject to amortization for 2023, the following four fiscal years and thereafter: Period/Year Total Amortization Expense (in thousands) 2023 $ 3,819 2024 $ 2,685 2025 $ 2,685 2026 $ 2,666 2027 $ 1,196 Thereafter $ 2,895 Total $ 15,946

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements	The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of December 31, 2022 and December 31, 2021: As of December 31, 2022 Fair Value Measurement Using: Carrying Amount Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in thousands) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 95,200 $ 95,200 $ — $ 95,200 $ — Deferred compensation fund Money Market 1 $ 2,420 $ 2,420 $ — $ 2,420 $ — Commodities 170 170 170 — — Fixed Income 3,571 3,571 3,571 — — International 4,093 4,093 4,093 — — Large Cap Blend 1,210 1,210 1,210 — — Large Cap Growth 11,064 11,064 11,064 — — Large Cap Value 6,133 6,133 6,133 — — Mid Cap Blend 2,667 2,667 2,667 — — Real Estate 359 359 359 — — Small Cap Blend 3,424 3,424 3,424 — — Deferred compensation fund 2 $ 35,111 $ 35,111 $ 32,691 $ 2,420 $ — As of December 31, 2021 Fair Value Measurement Using: Carrying Total Fair Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (in thousands) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 114,396 $ 114,396 $ — $ 114,396 $ — Deferred compensation fund Money Market 1 $ 2,882 $ 2,882 $ — $ 2,882 $ — Balanced and Lifestyle 12,578 12,578 12,578 — — Large Cap Growth 20,358 20,358 20,358 — — Small Cap Growth 6,561 6,561 6,561 — — Fixed Income 4,826 4,826 4,826 — — International 2,299 2,299 2,299 — — Mid Cap Growth 4,179 4,179 4,179 — — Deferred compensation fund $ 53,683 $ 53,683 $ 50,801 $ 2,882 $ — 1. The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment. 2. The deferred compensation fund carrying amounts and total fair value amounts as of December 31, 2022 and 2021 are inclusive of $1.6 million and $7.0 million of holdings expected to be paid to former employees within the next twelve months and were recorded under “Prepaid expenses and other assets” in the Company’s Consolidated Balance Sheets.
Schedule of Marketable Debt Securities	Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Other-than-temporary Impairments (in thousands) December 31, 2022 Type of security: Municipal bonds — available-for-sale $ 99,601 $ 229 $ (4,630) $ 95,200 $ — Total debt securities $ 99,601 $ 229 $ (4,630) $ 95,200 $ — December 31, 2021 Type of security: Municipal bonds — available-for-sale $ 109,331 $ 5,219 $ (154) $ 114,396 $ — Total debt securities $ 109,331 $ 5,219 $ (154) $ 114,396 $ — December 31, 2020 Type of security: Municipal bonds — available-for-sale $ 117,970 $ 7,043 $ (1) $ 125,012 $ — Total debt securities $ 117,970 $ 7,043 $ (1) $ 125,012 $ —
Schedule of Contractual Maturities of Available for Sale Investments	The following table summarizes the contractual maturities of debt securities held at December 31, 2022 and December 31, 2021, which are classified as marketable securities in the Company’s Consolidated Balance Sheets: Municipal Bonds — Available-for-Sale Contractual maturity: December 31, 2022 December 31, 2021 (in thousands) Maturing in one year or less $ 2,798 $ 5,606 Maturing in second year through fifth year 35,068 23,054 Maturing in sixth year through tenth year 38,575 52,180 Maturing after ten years 18,759 33,556 Total debt securities $ 95,200 $ 114,396

Accounts and Notes Receivable (

Accounts and Notes Receivable (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Accounts and Notes Receivable	The Company’s accounts and notes receivable balances consisted of the following as of December 31, 2022 and December 31, 2021: December 31, 2022 December 31, 2021 (in thousands) Short-term Accounts and notes receivable $ 406,969 $ 352,659 Allowance for doubtful accounts (70,192) (59,271) Total net short-term accounts and notes receivable $ 336,777 $ 293,388 Long-term Notes receivable $ 35,882 $ 35,571 Allowance for doubtful accounts (3,273) (6,312) Total net long-term notes receivable $ 32,609 $ 29,259 Total net accounts and notes receivable $ 369,386 $ 322,647

Allowance for Doubtful Accoun_2

Allowance for Doubtful Accounts (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Schedule of Notes Receivable Disaggregated by Vintage Year	The following table presents the Company’s two tiers of notes receivable for the years ended December 31, 2022 and 2021, respectively, further disaggregated by year of origination, as well as write-off activity: Notes Receivable as of December 31, 2022 Amortized Cost Basis by Origination Year 2022 2021 2020 2019 2018 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 31,406 $ 10,887 $ 1,683 $ 208 $ 13 $ 21,982 $ 66,179 Elevated risk notes receivable $ — $ — $ — $ — $ — $ 1,223 $ 1,223 Current-period gross write-offs $ 1 $ — $ 51 $ 54 $ — $ 491 $ 597 Current-period recoveries — — — — — — — Current-period net write-offs $ 1 $ — $ 51 $ 54 $ — $ 491 $ 597 Notes Receivable as of December 31, 2021 Amortized Cost Basis by Origination Year 2021 2020 2019 2018 2017 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 16,558 $ 6,862 $ 401 $ 18,738 $ 21,288 $ 1,560 $ 65,407 Elevated risk notes receivable $ — $ — $ — $ — $ 406 $ 1,374 $ 1,780 Current-period gross write-offs $ — $ — $ 541 $ 489 $ 2,494 $ — $ 3,524 Current-period recoveries — — (1) — — (38) (39) Current-period net write-offs $ — $ — $ 540 $ 489 $ 2,494 $ (38) $ 3,485
Schedule of Age Analysis of Past-Due Note Receivable	The following table provides information as to the status of payment on the Company’s gross notes receivable which were past due as of December 31, 2022 and 2021, respectively: Age Analysis of Past-Due Notes Receivable as of December 31, 2022 0-90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 894 $ 263 $ 3,330 $ 4,487 Elevated risk notes receivable — — 1,223 1,223 $ 894 $ 263 $ 4,553 $ 5,710 Age Analysis of Past-Due Notes Receivable as of December 31, 2021 0-90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 953 $ 5,676 $ 6,536 $ 13,165 Elevated risk notes receivable — — 1,780 1,780 $ 953 $ 5,676 $ 8,316 $ 14,945
Schedule of Accounts Receivable, Allowance for Doubtful Accounts	The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the years ended December 31, 2022 and 2021, respectively: Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 50,794 $ (16,825) $ 32,632 $ 66,601 Notes receivable Standard notes receivable $ 13,607 $ (6,783) $ (772) $ 6,052 Elevated risk notes receivable 1,183 (481) 109 811 Total notes receivable $ 14,790 $ (7,264) $ (663) $ 6,863 Total accounts and notes receivable $ 65,584 $ (24,089) $ 31,969 $ 73,464 1. Write-offs are shown net of recoveries. During the year ended December 31, 2022, the Company collected $0.3 million of accounts receivables that were recovered subsequent to being written-off. Adjustments include a reduction of $8.0 million of allowance for doubtful accounts which related to a contract modification during the year ended December 31, 2022. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 51,052 $ (9,215) $ 8,957 $ 50,794 Notes receivable Standard notes receivable $ 13,258 $ (183) $ 532 $ 13,607 Elevated risk notes receivable 3,491 (3,302) 994 1,183 Total notes receivable $ 16,749 $ (3,485) $ 1,526 $ 14,790 Total accounts and notes receivable $ 67,801 $ (12,700) $ 10,483 $ 65,584 1. Write-offs are shown net of recoveries. During the year ended December 31, 2021, the Company collected $0.2 million of accounts receivables that were recovered subsequent to being written-off.
Schedule of Allowance for Doubtful Accounts	The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the years ended December 31, 2022 and 2021, respectively: Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 50,794 $ (16,825) $ 32,632 $ 66,601 Notes receivable Standard notes receivable $ 13,607 $ (6,783) $ (772) $ 6,052 Elevated risk notes receivable 1,183 (481) 109 811 Total notes receivable $ 14,790 $ (7,264) $ (663) $ 6,863 Total accounts and notes receivable $ 65,584 $ (24,089) $ 31,969 $ 73,464 1. Write-offs are shown net of recoveries. During the year ended December 31, 2022, the Company collected $0.3 million of accounts receivables that were recovered subsequent to being written-off. Adjustments include a reduction of $8.0 million of allowance for doubtful accounts which related to a contract modification during the year ended December 31, 2022. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs/Adjustments 1 Bad Debt Expense December 31, (in thousands) Accounts receivable $ 51,052 $ (9,215) $ 8,957 $ 50,794 Notes receivable Standard notes receivable $ 13,258 $ (183) $ 532 $ 13,607 Elevated risk notes receivable 3,491 (3,302) 994 1,183 Total notes receivable $ 16,749 $ (3,485) $ 1,526 $ 14,790 Total accounts and notes receivable $ 67,801 $ (12,700) $ 10,483 $ 65,584 1. Write-offs are shown net of recoveries. During the year ended December 31, 2021, the Company collected $0.2 million of accounts receivables that were recovered subsequent to being written-off.

Lease Commitments (Tables)

Lease Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Schedule of Components of Lease Expense	Components of lease expense are presented below for the years ended December 31, 2022, 2021 and 2020. Year Ended December 31, 2022 2021 2020 (in thousands) Lease cost Operating lease cost $ 5,673 $ 6,210 $ 5,381 Short-term lease cost 1,265 747 738 Variable lease cost 857 973 464 Total lease cost $ 7,795 $ 7,930 $ 6,583
Schedule of Supplemental Information Required by ASC 842	Supplemental information is presented below for the years ended December 31, 2022, 2021 and 2020. Year Ended December 31, 2022 2021 2020 (dollar amounts in thousands) Other information Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 6,385 $ 6,609 $ 5,690 ROU Assets obtained in exchange for lease obligations $ 1,650 7,143 5,410 Weighted-average remaining lease term — operating leases 4.2 years 4.5 years 5.4 years Weighted-average discount rate — operating leases 4.4 % 4.2 % 4.5 %
Schedule of Future Minimum Lease Payments	The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of December 31, 2022: Period/Year Operating Leases (in thousands) 2023 $ 5,267 2024 3,502 2025 1,714 2026 1,337 2027 1,363 Thereafter 1,505 Total minimum lease payments $ 14,688 Less: imputed lease payments 1,317 Present value of lease liabilities $ 13,371

Share-Based Compensation (Table

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	The components of the Company’s share-based compensation expense for the years ended December 31, 2022, 2021 and 2020 are as follows: Year Ended December 31, 2022 2021 2020 (in thousands) Stock options $ 1,253 $ 1,832 $ 2,134 Restricted stock, restricted stock units and deferred stock units 6,972 6,367 5,195 Performance stock units 819 401 — Employee Stock Purchase Plan 170 227 543 Total pre-tax share-based compensation expense charged against income $ 9,214 $ 8,827 $ 7,872 Total recognized tax deficiency related to share-based compensation $ (783) $ (217) $ (293) The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive Income for the years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands) Selling, general & administrative expense $ 9,160 $ 8,767 $ 7,718 Costs of services provided 54 60 154 Total $ 9,214 $ 8,827 $ 7,872
Summary of Other Information of Stock Option Plans	A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2022 and changes during 2022 are as follows: Stock Options Outstanding Number of Shares Weighted Average Exercise Price (in thousands) December 31, 2021 2,181 $ 33.42 Granted 352 $ 18.10 Exercised (23) $ 17.50 Forfeited — $ — Expired (135) $ 28.99 December 31, 2022 2,375 $ 31.56
Schedule of Assumption For Fair Value of Options Granted	The fair value of stock option awards granted in 2022, 2021 and 2020 were estimated on the dates of grant using the Black-Scholes option valuation model with the following assumptions: Year Ended December 31, 2022 2021 2020 Risk-free interest rate 1.5 % 0.6 % 1.8 % Weighted average expected life 6.7 years 6.6 years 6.6 years Expected volatility 36.6 % 34.7 % 26.5 % Dividend yield 4.6 % 2.9 % 3.2 %
Summarized Information of Stock Options Outstanding	The following table summarizes other information about the stock options at December 31, 2022: December 31, 2022 (amounts in thousands, except per share data) Outstanding: Aggregate intrinsic value $ — Weighted average remaining contractual life 4.8 years Exercisable: Number of options 1,619 Weighted average exercise price $ 34.52 Aggregate intrinsic value $ — Weighted average remaining contractual life 3.3 years
Summary of Outstanding Restricted Stock Units and Restricted Stock	A summary of the outstanding restricted stock units and restricted stock as of December 31, 2021 and changes during the year ended December 31, 2022 is as follows: Restricted Stock Units and Restricted Stock Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 652 $ 31.03 Granted 410 $ 18.06 Vested (184) $ 33.68 Forfeited (53) $ 25.25 December 31, 2022 825 $ 24.37
Schedule of Weighted Average Grant-Date Fair Values and Intrinsic Values of Options Vested	The weighted average grant-date fair values and total fair values of restricted stock units and restricted stock vested during 2022, 2021 and 2020 were as follows: Year Ended December 31, 2022 2021 2020 (in thousands, except per share data) Weighted average grant-date fair value of restricted stock units granted $ 18.06 $ 28.53 $ 24.43 Total fair value of restricted stock units and restricted shares vested $ 3,307 $ 4,185 $ 2,287
Summary of Outstanding Performance Stock Units	A summary of the outstanding PSUs as of December 31, 2021 and changes during the year ended December 31, 2022 is as follows: Performance Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 35 $ 34.52 Granted 60 $ 21.00 Vested — $ — Forfeited — $ — December 31, 2022 95 $ 26.01
Summary of ESPP Annual Offerings	The following table summarizes information about the Company’s ESPP annual offerings for the years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands, except per share data) Common shares purchased 95 85 73 Per common share purchase price $ 10.20 $ 15.12 $ 20.67
Schedule of Options Granted Estimated Expense Valuation Assumptions	The expense associated with the options granted under the ESPP during the year ended December 31, 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Year Ended December 31, 2022 2021 Risk-free interest rate 0.4% 0.1% Weighted average expected life (years) 1.0 1.0 Expected volatility 36.9% 61.7% Dividend yield 4.7% 2.9%
Summary of Information Of SERP	The following table summarizes information about the SERP during the plan years ended December 31, 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 (in thousands) SERP expense 1 $ 486 $ 531 $ 512 Treasury shares issued to fund SERP expense 2 40 30 18 Year end SERP trust account balance 3 $ 35,111 $ 59,086 $ 54,729 Unrealized (loss) gain recorded in SERP liability account $ (9,178) $ 6,676 $ 9,200 1. Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income. 2. Shares related to the SERP match for each year are funded at the beginning of the subsequent year. 3. SERP trust account investments are recorded at their fair value which is based on quoted market prices. Differences between such amounts in the table above and the deferred compensation funding asset reported on the Company’s Consolidated Balance Sheets represent the value of Company common stock held in the Plan participants’ trust accounts and reported by the Company as treasury stock in the Company’s Consolidated Balance Sheets.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Summary of Provision for Income Taxes	The following table summarizes the provision for income taxes: Year Ended December 31, 2022 2021 2020 (amounts in thousands) Current: Federal $ 3,022 $ 9,120 $ 28,833 State 2,381 3,766 7,564 $ 5,403 $ 12,886 $ 36,397 Deferred: Federal $ 4,305 $ 2,118 $ (4,903) State 744 956 (990) $ 5,049 $ 3,074 $ (5,893) Tax provision $ 10,452 $ 15,960 $ 30,504
Significant Components of Federal and State Deferred Tax Assets and Liabilities	Significant components of the Company’s federal and state deferred tax asset and liability balances were as follows: Year Ended December 31, 2022 2021 (in thousands) Deferred tax assets: Allowance for doubtful accounts $ 18,139 $ 16,124 Deferred compensation 8,686 9,587 Deferred payroll taxes under the CARES Act — 6,220 Accrued insurance claims 5,609 6,252 Non-deductible reserves 256 521 Leases 227 247 Other 2,488 1,854 $ 35,405 $ 40,805 Deferred tax liabilities: Expensing of housekeeping supplies $ (2,510) $ (3,085) Amortization of goodwill and intangibles (2,389) (2,118) Depreciation of property and equipment (1,769) (1,915) Other (399) (2,152) $ (7,067) $ (9,270) Net deferred tax assets $ 28,338 $ 31,535
Reconciliation of The Provision for Income Taxes	The table below provides a reconciliation between the tax expense computed by applying the statutory federal income tax rate to income before income taxes and the provision for income taxes: Year Ended December 31, 2022 2021 2020 (in thousands) Income tax expense computed at statutory rate $ 9,467 $ 12,983 $ 27,129 Increases (decreases) resulting from: State income taxes, net of federal tax benefit 2,625 3,931 4,985 Federal jobs credits (2,571) (3,177) (3,089) Tax exempt interest (308) (324) (323) Share-based compensation 1,250 1,072 1,323 Fines and penalties 1 4 1,294 20 Other, net (15) 181 459 Income tax expense $ 10,452 $ 15,960 $ 30,504

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Information	Year Ended December 31, 2022 2021 2020 (in thousands) Revenues 1 Housekeeping $ 795,687 $ 821,329 $ 895,267 Dietary 894,489 820,630 865,036 Total $ 1,690,176 $ 1,641,959 $ 1,760,303 Income before income taxes Housekeeping $ 73,096 $ 79,380 $ 95,723 Dietary 29,065 45,758 68,293 Corporate 2 (57,079) (63,315) (34,830) Total $ 45,082 $ 61,823 $ 129,186 Depreciation and amortization Housekeeping $ 5,491 $ 5,399 $ 5,722 Dietary 3,075 2,611 2,394 Corporate 6,750 6,657 6,152 Consolidated $ 15,316 $ 14,667 $ 14,268 Total assets Housekeeping $ 250,444 $ 225,531 $ 214,500 Dietary 263,126 221,911 174,866 Corporate 3 204,764 330,087 395,665 Consolidated $ 718,334 $ 777,529 $ 785,031 Capital expenditures Housekeeping $ 4,412 $ 5,005 $ 3,710 Dietary 499 451 393 Corporate 299 231 238 Consolidated $ 5,210 $ 5,687 $ 4,341 1. For the years ended December 31, 2022 and 2021, both the Housekeeping and Dietary segments earned revenue from several significant customers, although Genesis was the only customer to contribute more than 10% of consolidated revenue. For the years ended December 31, 2022, 2021 and 2020, Genesis accounted for $169.1 million or 10.0%, $177.1 million or 10.8% and $258.7 million or 14.7% of the Company’s consolidated revenues, respectively. 2. Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense. 3. Primarily consists of cash and cash equivalents, marketable securities, deferred income taxes and other current and noncurrent assets.

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	The table below reconciles the weighted-average basic and diluted common shares outstanding for 2022, 2021 and 2020: Year Ended December 31, 2022 2021 2020 Numerator for basic and diluted earnings per share: Net income $ 34,630 $ 45,863 $ 98,682 Denominator: Weighted average number of common shares outstanding - basic 74,336 74,816 74,696 Effect of dilutive securities 1 15 146 89 Weighted average number of common shares outstanding - diluted 74,351 74,962 74,785 Basic earnings per share: $ 0.47 $ 0.61 $ 1.32 Diluted earnings per share: $ 0.47 $ 0.61 $ 1.32
Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans	Anti-dilutive outstanding equity awards under share-based compensation plans were as follows: Year Ended December 31, 2022 2021 2020 (in thousands) Anti-dilutive equity awards 3,203 1,980 2,121

Description of Business and S_4

Description of Business and Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) financial_institution segment	Dec. 31, 2021 USD ($) financial_institution	Dec. 31, 2020 USD ($)
Schedule of Accounting Policies [Line Items]
Renewal term	1 year
Number of reportable segments | segment	2
Marketable securities	$ 95,200,000	$ 114,396,000
Unrealized gains (losses) from marketable securities	$ (7,500,000)	(1,600,000)	$ 2,600,000
Payment terms	The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 4 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit losses.
Amortization period of inventories and supplies	24 months
Depreciation	$ 10,500,000	10,300,000	10,100,000
Advertising expense	0	0	0
Impairment of long-lived assets	0	0	0
Goodwill and intangible asset impairment	$ 0	$ 0	0
Number of financial institutions holding cash and cash equivalents and marketable securities | financial_institution	1	1
Revenues	$ 1,690,176,000	$ 1,641,959,000	$ 1,760,303,000
Genesis
Schedule of Accounting Policies [Line Items]
Accounts receivable	36,200,000
Notes receivable	$ 20,400,000
Significant Customers | Consolidated revenues | Genesis
Schedule of Accounting Policies [Line Items]
Concentration risk, percentage	10%	10.80%	14.70%
Revenues	$ 169,100,000	$ 177,100,000	$ 258,700,000
Vendor | Products and other items | Sysco
Schedule of Accounting Policies [Line Items]
Concentration risk, percentage	50%
Minimum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	30 days
Initial period preceding cancellation notice	60 days
Minimum | Housekeeping and Dietary equipment
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	3 years
Minimum | Computer hardware and software
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	3 years
Minimum | Vehicles
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	5 years
Maximum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	90 days
Initial period preceding cancellation notice	120 days
Maximum | Housekeeping and Dietary equipment
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	5 years
Maximum | Computer hardware and software
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	5 years
Maximum | Vehicles
Schedule of Accounting Policies [Line Items]
Property plant and equipment, useful life	10 years

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 1,690,176	$ 1,641,959	$ 1,760,303
Renewal term	1 year
Reduction in revenue	$ 10,000
Description of timing	The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
Transferred at point in time
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 300	100
Transferred over time
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 3,100	2,500
Minimum
Disaggregation of Revenue [Line Items]
Cancellation notice period	30 days
Initial period preceding cancellation notice	60 days
Maximum
Disaggregation of Revenue [Line Items]
Cancellation notice period	90 days
Initial period preceding cancellation notice	120 days
Housekeeping
Disaggregation of Revenue [Line Items]
Revenue	$ 795,700	821,300	895,300
Dietary
Disaggregation of Revenue [Line Items]
Revenue	$ 894,500	$ 820,600	$ 865,000

Revenue - Transaction Price All

Revenue - Transaction Price Allocated to Remaining Performance Obligation (Details) $ in Millions	Dec. 31, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Remaining performance obligation	$ 120.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 120.3
Remaining performance obligation percent	85.70%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation period	12 months

Changes in Accumulated Other _3

Changes in Accumulated Other Comprehensive Income by Component - Summary (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated other comprehensive income
Beginning balance	[1]	$ 452,677	$ 480,461	$ 460,305
Other comprehensive (loss) income before reclassifications		(7,505)	(1,522)	2,557
Losses (gains) reclassified from other comprehensive income		28	(41)	87
Net current period other comprehensive (loss) income		(7,477)	(1,563)	2,644
Ending balance	[1]	426,172	452,677	480,461
Realized loss		100		100
Realized gain			100
Changes in other comprehensive (loss) income, tax expense (benefit)		(2,000)	400	700
Accumulated Other Comprehensive Income (Loss), net of Taxes
Accumulated other comprehensive income
Beginning balance		4,000	5,563	2,919
Ending balance		$ (3,477)	$ 4,000	$ 5,563
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Changes in Accumulated Other _4

Changes in Accumulated Other Comprehensive Income by Component - Reclassification Adjustments (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
(Losses) gains from the sale of available-for-sale securities		$ (5,427)	$ 9,439	$ 13,352
Tax (expense) benefit		(10,452)	(15,960)	(30,504)
Net income for the period	[1]	34,630	45,863	98,682
Amounts Reclassified from Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income for the period		(28)	41	(87)
Realized Gains (Losses) on Sale of Available-for-sale Securities | Amounts Reclassified from Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
(Losses) gains from the sale of available-for-sale securities		(37)	55	(114)
Tax (expense) benefit		$ 9	$ (14)	$ 27
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property and equipment, net	Property and equipment, net
Operating lease — right-of-use assets	$ 34,445	$ 33,217
Total property and equipment, at cost	55,171	54,301
Less accumulated depreciation	32,196	26,199
Property and equipment, net	22,975	28,102
Depreciation	10,500	10,300	$ 10,100
ROU Assets depreciation	6,100	6,400	$ 5,600
Housekeeping and Dietary equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,585	13,468
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,086	5,880
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,055	$ 1,736

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Impairment of goodwill	$ 0
Amortization of intangible assets	$ 4,900,000	$ 4,400,000	$ 4,200,000
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	10 years
Trade names
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	13 years
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	8 years
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	4 years

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Goodwill by Reportable Segment (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 74,755
Acquisitions	774
Goodwill, Ending Balance	75,529
Measurement period adjustment	700
Housekeeping
Goodwill [Roll Forward]
Goodwill, Beginning Balance	42,377
Acquisitions	0
Goodwill, Ending Balance	42,377
Dietary
Goodwill [Roll Forward]
Goodwill, Beginning Balance	32,378
Acquisitions	774
Goodwill, Ending Balance	$ 33,152

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 48,684	$ 48,684
Accumulated Amortization	32,738	27,879
Net Amount	15,946	20,805
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	45,634	45,634
Accumulated Amortization	32,211	27,704
Net Amount	13,423	17,930
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross Amount	1,731	1,731
Accumulated Amortization	191	55
Net Amount	1,540	1,676
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Amount	1,086	1,086
Accumulated Amortization	232	95
Net Amount	854	991
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Gross Amount	233	233
Accumulated Amortization	104	25
Net Amount	$ 129	$ 208

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Estimated Amortization Expense For Intangibles Subject To Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 3,819
2024	2,685
2025	2,685
2026	2,666
2027	1,196
Thereafter	2,895
Total	$ 15,946	$ 20,805

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	$ (7,477)	$ (1,563)	$ 2,644
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds	10,386	26,697	6,269
Realized loss	100		100
Realized gain		100
Unrealized losses related to equity securities	9,300
Unrealized gains related to equity securities		6,500	9,500
Other long-term liabilities	6,141	10,456
Manufacturer of prepackaged meals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred variable consideration		10,600
Realized gains	2,400	100
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds	$ 10,400	26,700	$ 6,300
Realized gain		$ 100

Fair Value Measurements - Marke

Fair Value Measurements - Marketable Securities and Deferred Compensation Fund Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 95,200	$ 114,396	$ 125,012
Deferred compensation fund	33,493	46,691
Prepaid expenses and other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,600	7,000
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	32,691	50,801
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,420	2,882
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	35,111	53,683
Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	35,111	53,683
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	95,200	114,396	$ 125,012
Municipal bonds — available-for-sale | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	95,200	114,396
Municipal bonds — available-for-sale | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	95,200	114,396
Municipal bonds — available-for-sale | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	95,200	114,396
Money Market | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Money Market | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,420	2,882
Money Market | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Money Market | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,420	2,882
Money Market | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,420	2,882
Commodities | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	170
Commodities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Commodities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Commodities | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	170
Commodities | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	170
Fixed Income | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,571	4,826
Fixed Income | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Fixed Income | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Fixed Income | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,571	4,826
Fixed Income | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,571	4,826
International | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,093	2,299
International | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
International | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
International | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,093	2,299
International | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,093	2,299
Large Cap Blend | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,210
Large Cap Blend | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Large Cap Blend | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Large Cap Blend | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,210
Large Cap Blend | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,210
Large Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	11,064	20,358
Large Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Large Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Large Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	11,064	20,358
Large Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	11,064	20,358
Large Cap Value | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	6,133
Large Cap Value | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Large Cap Value | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Large Cap Value | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	6,133
Large Cap Value | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	6,133
Mid Cap Blend | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,667
Mid Cap Blend | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Mid Cap Blend | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Mid Cap Blend | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,667
Mid Cap Blend | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,667
Real Estate | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	359
Real Estate | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Real Estate | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Real Estate | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	359
Real Estate | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	359
Small Cap Blend | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,424
Small Cap Blend | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Small Cap Blend | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
Small Cap Blend | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,424
Small Cap Blend | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	$ 3,424
Balanced and Lifestyle | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		12,578
Balanced and Lifestyle | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Balanced and Lifestyle | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Balanced and Lifestyle | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		12,578
Balanced and Lifestyle | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		12,578
Small Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		6,561
Small Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Small Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Small Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		6,561
Small Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		6,561
Mid Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		4,179
Mid Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Mid Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		0
Mid Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		4,179
Mid Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund		$ 4,179

Fair Value Measurements - Mar_2

Fair Value Measurements - Marketable Debt Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost	$ 99,601	$ 109,331	$ 117,970
Gross Unrealized Gains	229	5,219	7,043
Gross Unrealized Losses	(4,630)	(154)	(1)
Estimated Fair Value	95,200	114,396	125,012
Other-than-temporary Impairments	0	0	0
Municipal bonds — available-for-sale
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost	99,601	109,331	117,970
Gross Unrealized Gains	229	5,219	7,043
Gross Unrealized Losses	(4,630)	(154)	(1)
Estimated Fair Value	95,200	114,396	125,012
Other-than-temporary Impairments	$ 0	$ 0	$ 0

Fair Value Measurements - Contr

Fair Value Measurements - Contractual Maturities of Debt Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Maturing in one year or less	$ 2,798	$ 5,606
Maturing in second year through fifth year	35,068	23,054
Maturing in sixth year through tenth year	38,575	52,180
Maturing after ten years	18,759	33,556
Total debt securities	$ 95,200	$ 114,396	$ 125,012

Accounts and Notes Receivable -

Accounts and Notes Receivable - Schedule of Accounts and Notes Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Short-term
Accounts and notes receivable	$ 406,969	$ 352,659
Allowance for doubtful accounts	(70,192)	(59,271)
Total net short-term accounts and notes receivable	336,777	293,388
Long-term
Notes receivable	35,882	35,571
Allowance for doubtful accounts	(3,273)	(6,312)
Total net long-term notes receivable	32,609	29,259
Total net accounts and notes receivable	$ 369,386	$ 322,647

Allowance for Doubtful Accoun_3

Allowance for Doubtful Accounts - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
One-time adjustment	$ 73,464	$ 65,584	$ 67,801
Interest income	1,100	1,200	1,700
Bad debt provision	$ 31,969	$ 10,483	$ 9,636
Adoption adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
One-time adjustment				$ 42,200

Allowance for Doubtful Accoun_4

Allowance for Doubtful Accounts - Notes Receivable Disaggregated by Vintage Year (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Current-period gross write-offs
2022	$ 1	$ 0
2021	0	0
2020	51	541
2019	54	489
2018	0	2,494
Prior	491	0
Current-period gross write-offs	597	3,524
Current-period recoveries
2022	0	0
2021	0	0
2020	0	(1)
2019	0	0
2018	0	0
Prior	0	(38)
Current-period recoveries	0	(39)
Current-period net write-offs
2022	1	0
2021	0	0
2020	51	540
2019	54	489
2018	0	2,494
Prior	491	(38)
Current-period net write-offs	597	3,485
Standard notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2022	31,406	16,558
2021	10,887	6,862
2020	1,683	401
2019	208	18,738
2018	13	21,288
Prior	21,982	1,560
Total	66,179	65,407
Current-period net write-offs
Current-period net write-offs		183
Elevated risk notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2022	0	0
2021	0	0
2020	0	0
2019	0	0
2018	0	406
Prior	1,223	1,374
Total	$ 1,223	1,780
Current-period net write-offs
Current-period net write-offs		$ 3,302

Allowance for Doubtful Accoun_5

Allowance for Doubtful Accounts - Age Analysis of Past-Due Note Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 5,710	$ 14,945
0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	894	953
91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	263	5,676
Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	4,553	8,316
Standard notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	66,179	65,407
Standard notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	4,487	13,165
Standard notes receivable | 0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	894	953
Standard notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	263	5,676
Standard notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	3,330	6,536
Elevated risk notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,223	1,780
Elevated risk notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,223	1,780
Elevated risk notes receivable | 0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0	0
Elevated risk notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0	0
Elevated risk notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 1,223	$ 1,780

Allowance for Doubtful Accoun_6

Allowance for Doubtful Accounts - Allowance for doubtful accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts receivable
Accounts receivable, Allowance for doubtful accounts, beginning balance	$ 50,794	$ 51,052
Write-Offs/Adjustments	(16,825)	(9,215)
Bad Debt Expense	32,632	8,957
Accounts receivable, Allowance for doubtful accounts, ending balance	66,601	50,794	$ 51,052
Notes receivable
Financing receivable reserves, beginning balance	14,790	16,749
Write-Offs/Adjustments	(7,264)
Write-Offs/Adjustments	(597)	(3,485)
Bad Debt Expense	(663)	1,526
Financing receivable reserves, ending balance	6,863	14,790	16,749
Total accounts and notes receivable, beginning balance	65,584	67,801
Write-Offs/Adjustments	(24,089)	(12,700)
Bad Debt Expense	31,969	10,483	9,636
Total accounts and notes receivable, ending balance	73,464	65,584	67,801
Accounts receivable recovered after write off	300	200
Standard notes receivable
Notes receivable
Financing receivable reserves, beginning balance	13,607	13,258
Write-Offs/Adjustments	(6,783)
Write-Offs/Adjustments		(183)
Bad Debt Expense	(772)	532
Financing receivable reserves, ending balance	6,052	13,607	13,258
Customer concession
Notes receivable
Write-Offs/Adjustments	8,000
Elevated risk notes receivable
Notes receivable
Financing receivable reserves, beginning balance	1,183	3,491
Write-Offs/Adjustments	(481)
Write-Offs/Adjustments		(3,302)
Bad Debt Expense	109	994
Financing receivable reserves, ending balance	$ 811	$ 1,183	$ 3,491

Lease Commitments - Additional

Lease Commitments - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lessee, Lease, Description [Line Items]
Termination option	1 year
Short-term lease obligation	$ 5.3	$ 6.5
Other Accrued Liability, Current, Statement of Financial Position [Extensible List]	Other Accrued Liabilities, Current	Other Accrued Liabilities, Current
ROU Assets and Lease Liabilities reduction due to cancellation	$ 1.7	$ 0.8
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year
Extension option	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	7 years
Extension option	5 years

Lease Commitments - Components

Lease Commitments - Components of Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Lease cost
Operating lease cost	$ 5,673	$ 6,210	$ 5,381
Short-term lease cost	1,265	747	738
Variable lease cost	857	973	464
Total lease cost	7,795	7,930	6,583
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	6,385	6,609	5,690
ROU Assets obtained in exchange for lease obligations	$ 1,650	$ 7,143	$ 5,410
Weighted-average remaining lease term — operating leases	4 years 2 months 12 days	4 years 6 months	5 years 4 months 24 days
Weighted-average discount rate — operating leases	4.40%	4.20%	4.50%

Lease Commitments - Schedule of

Lease Commitments - Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Leases [Abstract]
2023	$ 5,267
2024	3,502
2025	1,714
2026	1,337
2027	1,363
Thereafter	1,505
Total minimum lease payments	14,688
Less: imputed lease payments	1,317
Present value of lease liabilities	$ 13,371

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	$ 9,214	$ 8,827	$ 7,872
Total recognized tax deficiency related to share-based compensation	(783)	(217)	(293)
Selling, general & administrative expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	9,160	8,767	7,718
Costs of services provided
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	54	60	154
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	1,253	1,832	2,134
Restricted stock, restricted stock units and deferred stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	6,972	6,367	5,195
Performance stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	819	401	0
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax share-based compensation expense charged against income	$ 170	$ 227	$ 543

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - USD ($)			12 Months Ended
	Jun. 04, 2022	Jan. 04, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 15,800,000	$ 17,500,000
Period of expense of unrecognized compensation cost			2 years 9 months 18 days	2 years 7 months 6 days
Weighted average grant-date fair value of stock options granted (in dollars per share)			$ 4.06	$ 7.01	$ 4.66
Aggregate intrinsic value of stock options exercised			$ 100,000	$ 700,000	$ 1,300,000
Fair value of options vested			1,800,000	2,100,000	2,600,000
Tax benefit from exercise of stock options			$ 0	$ 0	$ 100,000
Weighted average grant-date fair value of restricted stock units granted			$ 18.06	$ 28.53	$ 24.43
SERP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of earned income on a pre-tax basis, deferred			25%
Percentage of match participants' deferrals			25%
Percentage of deferral in the form of common stock			15%
Full vest in matching contribution			3 years
Shares authorized for issuance (in shares)			1,000,000
Common stock reserved for future issuance (in shares)			300,000
Stock options vested and outstanding (in shares)			300,000
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)			400,000	300,000	300,000
Weighted average grant-date fair value of restricted stock units granted			$ 18.06	$ 28.53	$ 24.43
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock granted (in shares)			0	0	0
Restricted stock, restricted stock units and deferred stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of expense of unrecognized compensation cost			2 years 10 months 24 days
Restricted stock granted (in shares)			410,000
Weighted average grant-date fair value of restricted stock units granted			$ 18.06
Performance stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 1,200,000
Period of expense of unrecognized compensation cost			1 year 9 months 18 days
Restricted stock granted (in shares)		60,000	60,000
Weighted average grant-date fair value of restricted stock units granted			$ 21
Vesting period		3 years
Deferred stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 100,000
Period of expense of unrecognized compensation cost			4 months 24 days
Restricted stock granted (in shares)	20,000
Vesting period	1 year
Payout period	5 years
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grant (in shares)			1,900,000
Average weekly hours of work			20 hours
Requisite service period for plan participation eligibility			2 years
Stock options authorized to issue to employees (in shares)			4,100,000
Annual earnings withheld to purchase common stock			$ 21,250
Percent of IRS limitation			85%
Maximum fair value of common stock purchased			$ 25,000
ESPP purchase price of common stock, percent of market price			85%
ESPP purchase price of common stock, percent of market price offering period			85%
2020 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares)			4,700,000
Shares available for future grant (in shares)			1,400,000
Maximum term of grants			10 years

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of Stock Options Outstanding (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Number of Shares
Beginning of period (in shares) | shares	2,181
Granted (in shares) | shares	352
Exercised (in shares) | shares	(23)
Forfeited (in shares) | shares	0
Expired (in shares) | shares	(135)
End of period (in shares) | shares	2,375
Weighted Average Exercise Price
Beginning of period (in dollars per share) | $ / shares	$ 33.42
Granted (in dollars per share) | $ / shares	18.10
Exercised (in dollars per share) | $ / shares	17.50
Forfeited (in dollars per share) | $ / shares	0
Expired (in dollars per share) | $ / shares	28.99
End of period (in dollars per share) | $ / shares	$ 31.56

Share-Based Compensation - Assu

Share-Based Compensation - Assumptions for Fair Value of Options Granted (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Risk-free interest rate	1.50%	0.60%	1.80%
Weighted average expected life	6 years 8 months 12 days	6 years 7 months 6 days	6 years 7 months 6 days
Expected volatility	36.60%	34.70%	26.50%
Dividend yield	4.60%	2.90%	3.20%

Share-Based Compensation - Su_3

Share-Based Compensation - Summarized Information About Stock Awards (Details) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Outstanding:
Aggregate intrinsic value	$ 0
Weighted average remaining contractual life	4 years 9 months 18 days
Exercisable:
Number of options (in shares) | shares	1,619
Weighted average exercise price (in dollars per share) | $ / shares	$ 34.52
Aggregate intrinsic value	$ 0
Weighted average remaining contractual life	3 years 3 months 18 days

Share-Based Compensation - Su_4

Share-Based Compensation - Summary of Restricted Stock Units (Details) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted Average Grant Date Fair Value
Granted (in dollars per share)	$ 18.06	$ 28.53	$ 24.43
Restricted stock, restricted stock units and deferred stock units
Number
Beginning balance (in shares)	652
Granted (in shares)	410
Vested (in shares)	(184)
Forfeited (in shares)	(53)
Ending balance (in shares)	825	652
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 31.03
Granted (in dollars per share)	18.06
Vested (in dollars per share)	33.68
Forfeited (in dollars per share)	25.25
Ending balance (in dollars per share)	$ 24.37	$ 31.03

Share-Based Compensation - Weig

Share-Based Compensation - Weighted Average Remaining Grant-Date and Total Fair Values (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Weighted average grant-date fair value of restricted stock units granted	$ 18.06	$ 28.53	$ 24.43
Total fair value of restricted stock units and restricted shares vested	$ 3,307	$ 4,185	$ 2,287

Share-Based Compensation - Su_5

Share-Based Compensation - Summary of Outstanding Performance Stock Units (Details) - $ / shares		12 Months Ended
	Jan. 04, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted Average Grant Date Fair Value
Granted (in dollars per share)		$ 18.06	$ 28.53	$ 24.43
Performance stock units
Number
Beginning balance (in shares)		35,000
Granted (in shares)	60,000	60,000
Vested (in shares)		0
Forfeited (in shares)		0
Ending balance (in shares)		95,000	35,000
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)		$ 34.52
Granted (in dollars per share)		21
Vested (in dollars per share)		0
Forfeited (in dollars per share)		0
Ending balance (in dollars per share)		$ 26.01	$ 34.52

Share Based Compensation - Summ

Share Based Compensation - Summary of ESPP Annual Offerings (Details) - ESPP - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares purchased (in shares)	95	85	73
Per common share purchase price (in dollars per share)	$ 10.20	$ 15.12	$ 20.67

Share-Based Compensation - As_2

Share-Based Compensation - Assumptions For Employee Stock Purchase Plan (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.50%	0.60%	1.80%
Weighted average expected life (years)	6 years 8 months 12 days	6 years 7 months 6 days	6 years 7 months 6 days
Expected volatility	36.60%	34.70%	26.50%
Dividend yield	4.60%	2.90%	3.20%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.40%	0.10%
Weighted average expected life (years)	1 year	1 year
Expected volatility	36.90%	61.70%
Dividend yield	4.70%	2.90%

Share-Based Compensation - Defe

Share-Based Compensation - Deferred Compensation Plan (Details) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	$ 9,214	$ 8,827	$ 7,872
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	$ 486	$ 531	$ 512
Treasury shares issued to fund SERP expense (in shares)	40	30	18
Year end SERP trust account balance	$ 35,111	$ 59,086	$ 54,729
Unrealized (loss) gain recorded in SERP liability account	$ (9,178)	$ 6,676	$ 9,200

Other Employee Benefit Plans (D

Other Employee Benefit Plans (Details)	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
Maximum percentage of employee contribution	15%

Income Taxes - Summary of Provi

Income Taxes - Summary of Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current:
Federal	$ 3,022	$ 9,120	$ 28,833
State	2,381	3,766	7,564
Total	5,403	12,886	36,397
Deferred:
Federal	4,305	2,118	(4,903)
State	744	956	(990)
Total	5,049	3,074	(5,893)
Tax provision	$ 10,452	$ 15,960	$ 30,504

Income Taxes - Significant Comp

Income Taxes - Significant Components of Federal and State Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Allowance for doubtful accounts	$ 18,139	$ 16,124
Deferred compensation	8,686	9,587
Deferred payroll taxes under the CARES Act	0	6,220
Accrued insurance claims	5,609	6,252
Non-deductible reserves	256	521
Leases	227	247
Other	2,488	1,854
Deferred tax assets	35,405	40,805
Deferred tax liabilities:
Expensing of housekeeping supplies	(2,510)	(3,085)
Amortization of goodwill and intangibles	(2,389)	(2,118)
Depreciation of property and equipment	(1,769)	(1,915)
Other	(399)	(2,152)
Deferred tax liabilities	(7,067)	(9,270)
Net deferred tax assets	$ 28,338	$ 31,535

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of the Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income tax expense computed at statutory rate	$ 9,467	$ 12,983	$ 27,129
Increases (decreases) resulting from:
State income taxes, net of federal tax benefit	2,625	3,931	4,985
Federal jobs credits	(2,571)	(3,177)	(3,089)
Tax exempt interest	(308)	(324)	(323)
Share-based compensation	1,250	1,072	1,323
Fines and penalties	4	1,294	20
Other, net	(15)	181	459
Tax provision	10,452	15,960	30,504
Reclassification [Line Items]
Fines and penalties	4	$ 1,294	$ 20
Fines and penalties reclassified from Other, net
Increases (decreases) resulting from:
Fines and penalties	100
Reclassification [Line Items]
Fines and penalties	$ 100

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Uncertain tax positions	$ 0
Change in liability for unrecognized tax benefit	$ 0	$ 0

Segment Information - Schedule

Segment Information - Schedule of Segment Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	2
Segment Reporting Information [Line Items]
Revenues	$ 1,690,176	$ 1,641,959	$ 1,760,303
Income before income taxes	45,082	61,823	129,186
Depreciation and amortization	15,316	14,667	14,268
Total assets	718,334	777,529	785,031
Capital expenditures	5,210	5,687	4,341
Genesis | Consolidated revenues | Significant Customers
Segment Reporting Information [Line Items]
Revenues	$ 169,100	$ 177,100	$ 258,700
Contribution percent	10%	10.80%	14.70%
Housekeeping
Segment Reporting Information [Line Items]
Revenues	$ 795,700	$ 821,300	$ 895,300
Dietary
Segment Reporting Information [Line Items]
Revenues	894,500	820,600	865,000
Operating Segments | Housekeeping
Segment Reporting Information [Line Items]
Revenues	795,687	821,329	895,267
Income before income taxes	73,096	79,380	95,723
Depreciation and amortization	5,491	5,399	5,722
Total assets	250,444	225,531	214,500
Capital expenditures	4,412	5,005	3,710
Operating Segments | Dietary
Segment Reporting Information [Line Items]
Revenues	894,489	820,630	865,036
Income before income taxes	29,065	45,758	68,293
Depreciation and amortization	3,075	2,611	2,394
Total assets	263,126	221,911	174,866
Capital expenditures	499	451	393
Corporate and eliminations
Segment Reporting Information [Line Items]
Income before income taxes	(57,079)	(63,315)	(34,830)
Depreciation and amortization	6,750	6,657	6,152
Total assets	204,764	330,087	395,665
Capital expenditures	$ 299	$ 231	$ 238

Earnings Per Common Share - Sch

Earnings Per Common Share - Schedule of Weighted Average Number of Shares (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator for basic and diluted earnings per share:
Net income	[1]	$ 34,630	$ 45,863	$ 98,682
Denominator:
Weighted average number of common shares outstanding - basic (in shares)		74,336	74,816	74,696
Effect of dilutive securities (in shares)		15	146	89
Weighted average number of common shares outstanding - diluted (in shares)		74,351	74,962	74,785
Basic earnings per share (in dollars per share)		$ 0.47	$ 0.61	$ 1.32
Diluted earnings per share (in dollars per share)		$ 0.47	$ 0.61	$ 1.32
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Earnings Per Common Share - S_2

Earnings Per Common Share - Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Anti-dilutive equity awards (in shares)	3,203	1,980	2,121

Contractual Obligations and O_2

Contractual Obligations and Other Contingencies (Details)		12 Months Ended
	Oct. 15, 2021 USD ($)	Dec. 31, 2022 USD ($) covenant	Nov. 22, 2022 USD ($)	Dec. 31, 2021 USD ($)
Short-term Debt [Line Items]
Bank line of credit		$ 300,000,000
Borrowings under line of credit		$ 25,000,000		$ 0
Financial covenants | covenant		2
Reduction of bank line of credit		$ 81,000,000
Amount available under line of credit		194,000,000
Line of Credit | Revolving Credit Facility | Unsecured Revolving Loan Facility
Short-term Debt [Line Items]
Bank line of credit			$ 300,000,000
Accordion feature, higher borrowing capacity option			$ 500,000,000
Shareholder class action
Short-term Debt [Line Items]
Litigation settlement	$ 16,800,000
Standby letters of credit
Short-term Debt [Line Items]
Irrevocable standby letter of credit, outstanding		$ 81,000,000
SOFR
Short-term Debt [Line Items]
Basis spread on variable rate		1.65%

Accrued Insurance Claims (Detai

Accrued Insurance Claims (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Percent of liabilities	30.40%	27.50%
Favorable adjustment in self-insurance reserves	$ (9.8)

Treasury Stock (Details)

Treasury Stock (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Purchase of treasury stock (in shares)	0	1,000,000
Purchase of treasury stock	$ 0	$ 21,535	[1]
[1]See Note 8 — Allowance for Doubtful Accounts herein regarding the adopted credit-loss guidance.

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts and Reserves (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning Balance	$ 65,583	$ 67,801	$ 52,393
Additions
Charged to Other Accounts	0	0	42,236
Charged to Costs and Expenses	31,969	10,483	9,636
Deductions	24,088	12,700	36,464
Ending Balance	$ 73,464	$ 65,583	$ 67,801